Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-10-07 20:57 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3CompletedINTERVENTIONAL

A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes

ClinicalTrials.gov · NCT02963766 · Registry updated: 2022-07-01

Condition / research focus: Type 2 Diabetes
Sponsor: Eli Lilly and Company
Countries with listed sites: Brazil · France · Germany · Hungary · India · Mexico · Puerto Rico · Saudi Arabia · Turkey (Türkiye) · United Kingdom · United States
Registry dates and results: Start: 2016-12-29. Completion: 2022-01-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide (drug) — also listed as: LY2189265
Placebo (drug)

Where the study takes place — 61 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

University of Alabama Birmingham
Birmingham, Alabama, United States
Site recruitment: Not reported
University of Arizona
Tucson, Arizona, United States
Site recruitment: Not reported
Advanced Research Center
Anaheim, California, United States
Site recruitment: Not reported
Division of Endocrinology, Diabetes, and Metabolism
Los Angeles, California, United States
Site recruitment: Not reported
Childrens Hospital of Orange County
Orange, California, United States
Site recruitment: Not reported
Center of Excellence in Diabetes & Endocrinology
Sacramento, California, United States
Site recruitment: Not reported
Rady Childrens Hospital - San Diego
San Diego, California, United States
Site recruitment: Not reported
JC Cabaccan
San Jose, California, United States
Site recruitment: Not reported
Touro University
Vallejo, California, United States
Site recruitment: Not reported
Children's National Medical Center
Washington D.C., District of Columbia, United States
Site recruitment: Not reported
Florida Center for Endocrinology & Metabolism
Orlando, Florida, United States
Site recruitment: Not reported
St. Luke's Regional Medical Center
Boise, Idaho, United States
Site recruitment: Not reported
University of Illinois at Chicago
Chicago, Illinois, United States
Site recruitment: Not reported
Indiana University Health Hospital
Indianapolis, Indiana, United States
Site recruitment: Not reported
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Site recruitment: Not reported
Children's Mercy Hospital
Kansas City, Missouri, United States
Site recruitment: Not reported
ECU Pediatric Specialty Care
Greenville, North Carolina, United States
Site recruitment: Not reported
Cincinnati Childrens Hospital Medical Center
Cincinnati, Ohio, United States
Site recruitment: Not reported
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Childrens Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
Seattle Children's Hospital Research Foundation
Seattle, Washington, United States
Site recruitment: Not reported
Multicare Health System
Tacoma, Washington, United States
Site recruitment: Not reported
CAMC Institute
Charleston, West Virginia, United States
Site recruitment: Not reported
Instituto Estadual de Diabetes e Endocrinologia
Rio de Janeiro, Rio de Janeiro, Brazil
Site recruitment: Not reported
Centro de Pesquisas em Diabetes
Porto Alegre, Rio Grande do Sul, Brazil
Site recruitment: Not reported
Instituto da Criança com Diabetes
Porto Alegre, Rio Grande do Sul, Brazil
Site recruitment: Not reported
Hospital PUC-CAMPINAS
Campinas, São Paulo, Brazil
Site recruitment: Not reported
Hospital das Clinicas da FMRP
Ribeirão Preto, São Paulo, Brazil
Site recruitment: Not reported
CPCLIN
São Paulo, São Paulo, Brazil
Site recruitment: Not reported
Hospital da Clinicas da Faculdade de Medicina da USP
São Paulo, São Paulo, Brazil
Site recruitment: Not reported
UNIFESP - Escola Paulista de Medicina
São Paulo, Brazil
Site recruitment: Not reported
Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre
Le Kremlin-Bicêtre, France
Site recruitment: Not reported
Hopital Robert Debre
Paris, France
Site recruitment: Not reported
Praxis Dr. med. Landers
Mayen, Rhineland-Palatinate, Germany
Site recruitment: Not reported
Zentrum für klinische Studien
Sankt Ingbert, Saarland, Germany
Site recruitment: Not reported
RED-Institut GmbH
Oldenburg in Holstein, Schleswig-Holstein, Germany
Site recruitment: Not reported
Heim Pal Gyermekkorhaz
Budapest, Hungary
Site recruitment: Not reported
Dr Jivraj Mehta Smarak Health Foundation Bakeri Medical Research Centre
Ahmedabad, Gujarat, India
Site recruitment: Not reported
Manipal Hospital
Bangalore, Karmnataka, India
Site recruitment: Not reported
M S Ramaiah Medical College Hospital
Bangalore, Karnataka, India
Site recruitment: Not reported
Deenanath Mangeshkar Hospital & Research Centre
Pune, Maharashtra, India
Site recruitment: Not reported
Sir Ganga Ram Hospital
New Delhi, National Capital Territory of Delhi, India
Site recruitment: Not reported
Post Graduate Institute of Medical Education & Research
Chandigarh, Punjab, India
Site recruitment: Not reported
Banaras Hindu University - BHU
Varanasi, Uttar Pradesh, India
Site recruitment: Not reported
Park Clinic
Kolkata, West Bengal, India
Site recruitment: Not reported
Apollo Gleneagles Hospitals Kolkata
Kolkata, West Bengal, India
Site recruitment: Not reported
Health Pharma Professional Research, S.A. de C.V.
Mexico City, Federal District, Mexico
Site recruitment: Not reported
Centro de Inv. Medica de Occidente, SC
Zapopan, Jalisco, Mexico
Site recruitment: Not reported
Centro Medico San Francisco
Monterrey, Nuevo León, Mexico
Site recruitment: Not reported
Cli-nica Hospital Cemain
Tampico, Tamaulipas, Mexico
Site recruitment: Not reported
Hospital Angeles Puebla
Puebla City, Mexico
Site recruitment: Not reported
Arke Estudios Clinicos S.A. de C.V.
Veracruz, Mexico
Site recruitment: Not reported
Centro de Diabetes y Endocrinologia Pediatrica de PR
Bayamón, PR, Puerto Rico
Site recruitment: Not reported
King Saud University Hospital
Riyadh, Saudi Arabia
Site recruitment: Not reported
King Salman bin Abdulaziz Hospital - Diabetic Center
Riyadh, Saudi Arabia
Site recruitment: Not reported
Ankara University Medicine Hospital
Ankara, Mamak, Turkey (Türkiye)
Site recruitment: Not reported
Sami Ulus Education & Research Hospital
Ankara, Turkey (Türkiye)
Site recruitment: Not reported
Duzce University Medical Faculty
Düzce, Turkey (Türkiye)
Site recruitment: Not reported
Ondokuz Mayis University Medical Faculty
Samsun, Turkey (Türkiye)
Site recruitment: Not reported
Alder Hey Children's Hospital
Liverpool, Lancashire, United Kingdom
Site recruitment: Not reported
St James's University Hospital
Leeds, West Yorkshire, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

A Study of TG103 Injection in Type 2 Diabetes Subjects

ClinicalTrials.gov · NCT05348122 · Registry updated: 2022-06-13

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Countries with listed sites: China
Registry dates and results: Start: 2022-06-15. Completion: 2023-11-01 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

TG103,Q2W (drug) — also listed as: TG103 injection, subcutaneous injection,Q2W
TG103,QW (drug) — also listed as: TG103 injection, subcutaneous injection,QW
Placebo,Q2W (drug) — also listed as: Placebo, subcutaneous injection,Q2W
Placebo,QW (drug) — also listed as: Placebo, subcutaneous injection,QW
Dulaglutide,QW (drug) — also listed as: Dulaglutide,subcutaneous injection,QW

Where the study takes place — 1 listed sites

Gao Huanhuan
Shijiazhuang, Hebei, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes

ClinicalTrials.gov · NCT03861052 · Registry updated: 2022-04-14

Condition / research focus: Type 2 Diabetes
Sponsor: Eli Lilly and Company
Countries with listed sites: Japan
Registry dates and results: Start: 2019-05-07. Completion: 2021-03-31 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176
Dulaglutide (drug) — also listed as: LY2189265

Where the study takes place — 46 listed sites

Akaicho Clinic
Chiba, Chiba, Japan
Site recruitment: Not reported
Medical corporation THY Tokuyama Clinic
Chiba Mihama-ku, Chiba, Japan
Site recruitment: Not reported
National Hospital Organization Kure Medical Center
Kure, Hiroshima, Japan
Site recruitment: Not reported
Hasegawa Medical Clinic
Chitose, Hokkaido, Japan
Site recruitment: Not reported
Yuri Ono Clinic
Sapporo, Hokkaido, Japan
Site recruitment: Not reported
Watanabe Naika Clinic
Nishinomiya, Hyōgo, Japan
Site recruitment: Not reported
Hayashi Clinic
Nishinomiya, Hyōgo, Japan
Site recruitment: Not reported
Naka Memorial Clinic
Naka, Ibaraki, Japan
Site recruitment: Not reported
Hayashi Diabetes Internal Medicine Clinic
Chigasaki-sh, Kanagawa, Japan
Site recruitment: Not reported
Matoba Diabetes Clinic
Ebina, Kanagawa, Japan
Site recruitment: Not reported
Takai Naika Clinic
Kamakura, Kanagawa, Japan
Site recruitment: Not reported
Kanto Rosai Hospital
Kawasaki, Kanagawa, Japan
Site recruitment: Not reported
H.E.C. Science Clinic
Yokohama, Kanagawa, Japan
Site recruitment: Not reported
Medical Corporation Heishinkai OCROM Clinic
Suita-shi, Osaka, Japan
Site recruitment: Not reported
Takatsuki Red Cross Hospital
Takatsuki, Osaka, Japan
Site recruitment: Not reported
Senrichuo Ekimae Clinic
Toyonaka, Osaka, Japan
Site recruitment: Not reported
Asano Clinic
Kawagoe, Saitama, Japan
Site recruitment: Not reported
Kawaguchi General Hospital
Kawaguchi, Saitama, Japan
Site recruitment: Not reported
Wakakusa Clinic
Shimotsuke, Tochigi, Japan
Site recruitment: Not reported
Seiwa Clinic
Adachi-ku, Tokyo, Japan
Site recruitment: Not reported
HDC Atlas Clinic
Chiyoda City, Tokyo, Japan
Site recruitment: Not reported
Meiwa Hospital
Chiyodaku, Tokyo, Japan
Site recruitment: Not reported
Asahi Life Foundation Adult Disease Research Center
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Nihonbashi Sakura Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Tokyo-Eki Center-building Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Medical Corporation Chiseikai Tokyo Center Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Tokyo aSBo Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Fukuwa Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
IHL Shinagawa East One Medical Clinic
Minato-ku, Tokyo, Japan
Site recruitment: Not reported
Sato Medical Clinic
Ootaku, Tokyo, Japan
Site recruitment: Not reported
Shinjuku Research Park Clinic
Shinjuku, Tokyo, Japan
Site recruitment: Not reported
Medical Corporation Heishinkai ToCROM Clinic
Shinjuku-ku, Tokyo, Japan
Site recruitment: Not reported
Tomonaga Clinic
Shinjuku-ku, Tokyo, Japan
Site recruitment: Not reported
Shinei Clinic
Suginami, Tokyo, Japan
Site recruitment: Not reported
Ikebukuro Metropolitan Clinic
Toshima-ku, Tokyo, Japan
Site recruitment: Not reported
Futata Tetsuhiro Clinic
Fukuoka, Japan
Site recruitment: Not reported
JR Hiroshima Hospital
Hiroshima, Japan
Site recruitment: Not reported
Yoshimura Clinic
Kumamoto, Japan
Site recruitment: Not reported
Keiseikai Kajiyama Clinic
Kyoto, Japan
Site recruitment: Not reported
OKAYAMA Medical Center
Okayama, Japan
Site recruitment: Not reported
AMC Nishiumeda Clinic
Osaka, Japan
Site recruitment: Not reported
Kitada Clinic
Osaka, Japan
Site recruitment: Not reported
Nanko Clinic
Osaka, Japan
Site recruitment: Not reported
Abe Clinic
Ōita, Japan
Site recruitment: Not reported
Suruga Clinic
Shizuoka, Japan
Site recruitment: Not reported
Yokohama Minoru Clinic
Yokohama, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes

ClinicalTrials.gov · NCT04374578 · Registry updated: 2022-03-31

Condition / research focus: Type 2 Diabetes
Sponsor: Shanghai Zhongshan Hospital
Countries with listed sites: China
Registry dates and results: Start: 2020-05-08. Completion: 2021-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide 1.5 MG/ML (drug)

Where the study takes place — 1 listed sites

180 Fenglin Road
Shanghai, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period

ClinicalTrials.gov · NCT02787551 · Registry updated: 2022-03-25

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: Sanofi
Countries with listed sites: Canada · Estonia · Germany · Israel · Italy · Romania · Slovakia · Spain · United States
Registry dates and results: Start: 2016-07-06. Completion: 2018-11-17 (may be estimated). Results are posted in this registry.

Products and interventions (7)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Insulin glargine/lixisenatide fixed ratio combination (drug) — also listed as: HOE901/AVE0010, Soliqua
liraglutide (drug) — also listed as: Victoza
exenatide (drug) — also listed as: Byetta
exenatide extended-release (drug) — also listed as: Bydureon
albiglutide (drug) — also listed as: Tanzeum
dulaglutide (drug) — also listed as: Trulicity
Background therapy: Oral Anti-diabetic Drug (Metformin, Pioglitazone, SGLT2 inhibitor) (drug)

Where the study takes place — 124 listed sites

Investigational Site Number 8400064
Birmingham, Alabama, United States
Site recruitment: Not reported
Investigational Site Number 8400073
Fountain Hills, Arizona, United States
Site recruitment: Not reported
Investigational Site Number 8400047
Phoenix, Arizona, United States
Site recruitment: Not reported
Investigational Site Number 8400103
Bakersfield, California, United States
Site recruitment: Not reported
Investigational Site Number 8400137
Fresno, California, United States
Site recruitment: Not reported
Investigational Site Number 8400043
Huntington Park, California, United States
Site recruitment: Not reported
Investigational Site Number 8400124
Lamont, California, United States
Site recruitment: Not reported
Investigational Site Number 8400027
Lancaster, California, United States
Site recruitment: Not reported
Investigational Site Number 8400098
Los Angeles, California, United States
Site recruitment: Not reported
Investigational Site Number 8400013
Los Angeles, California, United States
Site recruitment: Not reported
Investigational Site Number 8400042
Mission Hills, California, United States
Site recruitment: Not reported
Investigational Site Number 8400006
Northridge, California, United States
Site recruitment: Not reported
Investigational Site Number 8400021
Orange, California, United States
Site recruitment: Not reported
Investigational Site Number 8400126
Rialto, California, United States
Site recruitment: Not reported
Investigational Site Number 8400094
Santa Ana, California, United States
Site recruitment: Not reported
Investigational Site Number 8400009
Ventura, California, United States
Site recruitment: Not reported
Investigational Site Number 8400071
Denver, Colorado, United States
Site recruitment: Not reported
Investigational Site Number 8400036
Denver, Colorado, United States
Site recruitment: Not reported
Investigational Site Number 8400114
Jacksonville, Florida, United States
Site recruitment: Not reported
Investigational Site Number 8400133
Miami, Florida, United States
Site recruitment: Not reported
Investigational Site Number 8400058
Port Charlotte, Florida, United States
Site recruitment: Not reported
Investigational Site Number 8400084
Tampa, Florida, United States
Site recruitment: Not reported
Investigational Site Number 8400112
West Palm Beach, Florida, United States
Site recruitment: Not reported
Investigational Site Number 8400045
Lawrenceville, Georgia, United States
Site recruitment: Not reported
Investigational Site Number 8400096
Snellville, Georgia, United States
Site recruitment: Not reported
Investigational Site Number 8400023
Springfield, Illinois, United States
Site recruitment: Not reported
Investigational Site Number 8400049
Avon, Indiana, United States
Site recruitment: Not reported
Investigational Site Number 8400053
Avon, Indiana, United States
Site recruitment: Not reported
Investigational Site Number 8400085
Avon, Indiana, United States
Site recruitment: Not reported
Investigational Site Number 8400120
Avon, Indiana, United States
Site recruitment: Not reported
Investigational Site Number 8400041
Evansville, Indiana, United States
Site recruitment: Not reported
Investigational Site Number 8400038
Indianapolis, Indiana, United States
Site recruitment: Not reported
Investigational Site Number 8400130
Council Bluffs, Iowa, United States
Site recruitment: Not reported
Investigational Site Number 8400034
Lexington, Kentucky, United States
Site recruitment: Not reported
Investigational Site Number 8400091
Lexington, Kentucky, United States
Site recruitment: Not reported
Investigational Site Number 8400078
Marrero, Louisiana, United States
Site recruitment: Not reported
Investigational Site Number 8400032
Metairie, Louisiana, United States
Site recruitment: Not reported
Investigational Site Number 8400088
New Orleans, Louisiana, United States
Site recruitment: Not reported
Investigational Site Number 8400033
Baltimore, Maryland, United States
Site recruitment: Not reported
Investigational Site Number 8400051
Jefferson City, Missouri, United States
Site recruitment: Not reported
Investigational Site Number 8400083
Papillion, Nebraska, United States
Site recruitment: Not reported
Investigational Site Number 8400044
Henderson, Nevada, United States
Site recruitment: Not reported
Investigational Site Number 8400079
Albany, New York, United States
Site recruitment: Not reported
Investigational Site Number 8400061
New York, New York, United States
Site recruitment: Not reported
Investigational Site Number 8400123
North Massapequa, New York, United States
Site recruitment: Not reported
Investigational Site Number 8400095
Staten Island, New York, United States
Site recruitment: Not reported
Investigational Site Number 8400067
West Seneca, New York, United States
Site recruitment: Not reported
Investigational Site Number 8400111
Yonkers, New York, United States
Site recruitment: Not reported
Investigational Site Number 8400020
Morehead City, North Carolina, United States
Site recruitment: Not reported
Investigational Site Number 8400065
Wilmington, North Carolina, United States
Site recruitment: Not reported
Investigational Site Number 8400018
Fargo, North Dakota, United States
Site recruitment: Not reported
Investigational Site Number 8400019
Columbus, Ohio, United States
Site recruitment: Not reported
Investigational Site Number 8400056
Dayton, Ohio, United States
Site recruitment: Not reported
Investigational Site Number 8400125
Mentor, Ohio, United States
Site recruitment: Not reported
Investigational Site Number 8400099
Oklahoma City, Oklahoma, United States
Site recruitment: Not reported
Investigational Site Number 8400129
Scottdale, Pennsylvania, United States
Site recruitment: Not reported
Investigational Site Number 8400076
Smithfield, Pennsylvania, United States
Site recruitment: Not reported
Investigational Site Number 8400104
Warwick, Rhode Island, United States
Site recruitment: Not reported
Investigational Site Number 8400090
Columbia, South Carolina, United States
Site recruitment: Not reported
Investigational Site Number 8400139
Austin, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400001
Dallas, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400118
Edinburg, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400008
Houston, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400109
Houston, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400063
Houston, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400106
Houston, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400014
North Richland Hills, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400089
San Antonio, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400135
Schertz, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400075
Shavano Park, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400107
Sugar Land, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400054
Orem, Utah, United States
Site recruitment: Not reported
Investigational Site Number 8400025
Salt Lake City, Utah, United States
Site recruitment: Not reported
Investigational Site Number 8400092
Weber City, Virginia, United States
Site recruitment: Not reported
Investigational Site Number 1240003
Burlington, Canada
Site recruitment: Not reported
Investigational Site Number 1240006
Corunna, Canada
Site recruitment: Not reported
Investigational Site Number 1240002
Red Deer, Canada
Site recruitment: Not reported
Investigational Site Number 1240001
Vancouver, Canada
Site recruitment: Not reported
Investigational Site Number 2330002
Pärnu, Estonia
Site recruitment: Not reported
Investigational Site Number 2330003
Tallinn, Estonia
Site recruitment: Not reported
Investigational Site Number 2330001
Tallinn, Estonia
Site recruitment: Not reported
Investigational Site Number 2330004
Viljandi, Estonia
Site recruitment: Not reported
Investigational Site Number 2760001
Dresden, Germany
Site recruitment: Not reported
Investigational Site Number 2760003
Oldenburg in Holstein, Germany
Site recruitment: Not reported
Investigational Site Number 3760001
Haifa, Israel
Site recruitment: Not reported
Investigational Site Number 3760002
Haifa, Israel
Site recruitment: Not reported
Investigational Site Number 3760005
Jerusalem, Israel
Site recruitment: Not reported
Investigational Site Number 3760006
Jerusalem, Israel
Site recruitment: Not reported
Investigational Site Number 3760004
Tel Aviv, Israel
Site recruitment: Not reported
Investigational Site Number 3800008
Bergamo, Italy
Site recruitment: Not reported
Investigational Site Number 3800002
Bologna, Italy
Site recruitment: Not reported
Investigational Site Number 3800001
Milan, Italy
Site recruitment: Not reported
Investigational Site Number 3800006
Milan, Italy
Site recruitment: Not reported
Investigational Site Number 3800005
Naples, Italy
Site recruitment: Not reported
Investigational Site Number 3800004
Roma, Italy
Site recruitment: Not reported
Investigational Site Number 3800003
Roma, Italy
Site recruitment: Not reported
Investigational Site Number 6420004
Bacau, Romania
Site recruitment: Not reported
Investigational Site Number 6420006
Brasov, Romania
Site recruitment: Not reported
Investigational Site Number 6420001
Bucharest, Romania
Site recruitment: Not reported
Investigational Site Number 6420008
Buzău, Romania
Site recruitment: Not reported
Investigational Site Number 6420003
Cluj-Napoca, Romania
Site recruitment: Not reported
Investigational Site Number 6420002
Oradea, Romania
Site recruitment: Not reported
Investigational Site Number 6420009
Targoviste, Romania
Site recruitment: Not reported
Investigational Site Number 6420007
Târgu Mureş, Romania
Site recruitment: Not reported
Investigational Site Number 6420005
Timișoara, Romania
Site recruitment: Not reported
Investigational Site Number 7030006
Bratislava, Slovakia
Site recruitment: Not reported
Investigational Site Number 7030002
Lučenec, Slovakia
Site recruitment: Not reported
Investigational Site Number 7030009
Ľubochňa, Slovakia
Site recruitment: Not reported
Investigational Site Number 7030005
Malacky, Slovakia
Site recruitment: Not reported
Investigational Site Number 7030007
Prešov, Slovakia
Site recruitment: Not reported
Investigational Site Number 7030001
Rožňava, Slovakia
Site recruitment: Not reported
Investigational Site Number 7030008
Sabinov, Slovakia
Site recruitment: Not reported
Investigational Site Number 7030004
Trenčín, Slovakia
Site recruitment: Not reported
Investigational Site Number 7030003
Žilina, Slovakia
Site recruitment: Not reported
Investigational Site Number 7240012
Alzira, Spain
Site recruitment: Not reported
Investigational Site Number 7240005
Barcelona, Spain
Site recruitment: Not reported
Investigational Site Number 7240002
Ferrol, Spain
Site recruitment: Not reported
Investigational Site Number 7240008
Málaga, Spain
Site recruitment: Not reported
Investigational Site Number 7240011
Pozuelo de Alarcón, Spain
Site recruitment: Not reported
Investigational Site Number 7240003
Quart de Poblet, Spain
Site recruitment: Not reported
Investigational Site Number 7240006
Sabadell, Spain
Site recruitment: Not reported
Investigational Site Number 7240007
Seville, Spain
Site recruitment: Not reported
Investigational Site Number 7240009
Seville, Spain
Site recruitment: Not reported
Investigational Site Number 7240004
Seville, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin

ClinicalTrials.gov · NCT04829903 · Registry updated: 2022-03-14

Condition / research focus: Type 2 Diabetes Treated With Insulin; Obesity; Adolescent Obesity
Sponsor: Corporacion Parc Tauli
Countries with listed sites: Pakistan
Registry dates and results: Start: 2020-01-02. Completion: 2021-11-20 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide (drug) — also listed as: Group DUL
Liraglutide (drug) — also listed as: Group LIR

Where the study takes place — 1 listed sites

Zainab Khan
Lahore, Punjab Province, Pakistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes

ClinicalTrials.gov · NCT04641312 · Registry updated: 2022-01-11

Condition / research focus: Healthy; Type 2 Diabetes
Sponsor: Eli Lilly and Company
Countries with listed sites: Germany
Registry dates and results: Start: 2020-11-25. Completion: 2021-12-21 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

LY3457263 (drug)
Dulaglutide (drug) — also listed as: LY2189265
Placebo (drug)

Where the study takes place — 2 listed sites

Profil Institut für Stoffwechselforschung
Neuss, North Rhine-Westphalia, Germany
Site recruitment: Not reported
Profil Mainz
Mainz, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3TerminatedINTERVENTIONAL

Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin

ClinicalTrials.gov · NCT03684642 · Registry updated: 2021-11-01

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: Sanofi
Countries with listed sites: Hungary · Poland · Ukraine · United States
Registry dates and results: Start: 2018-09-26. Completion: 2020-11-17 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Efpeglenatide (drug) — also listed as: SAR439977
Dulaglutide (drug) — also listed as: Trulicity™
Background therapy Metformin (drug)

Where the study takes place — 45 listed sites

Investigational Site Number 8400038
Birmingham, Alabama, United States
Site recruitment: Not reported
Investigational Site Number 8400035
Chandler, Arizona, United States
Site recruitment: Not reported
Investigational Site Number 8400005
Glendale, Arizona, United States
Site recruitment: Not reported
Investigational Site Number 8400054
Peoria, Arizona, United States
Site recruitment: Not reported
Investigational Site Number 8400057
Huntington Park, California, United States
Site recruitment: Not reported
Investigational Site Number 8400009
Los Angeles, California, United States
Site recruitment: Not reported
Investigational Site Number 8400007
San Diego, California, United States
Site recruitment: Not reported
Investigational Site Number 8400045
Spring Valley, California, United States
Site recruitment: Not reported
Investigational Site Number 8400040
Tustin, California, United States
Site recruitment: Not reported
Investigational Site Number 8400026
Van Nuys, California, United States
Site recruitment: Not reported
Investigational Site Number 8400050
Waterbury, Connecticut, United States
Site recruitment: Not reported
Investigational Site Number 8400055
Orlando, Florida, United States
Site recruitment: Not reported
Investigational Site Number 8400041
Pembroke Pines, Florida, United States
Site recruitment: Not reported
Investigational Site Number 8400025
Lawrenceville, Georgia, United States
Site recruitment: Not reported
Investigational Site Number 8400060
Meridian, Idaho, United States
Site recruitment: Not reported
Investigational Site Number 8400059
Skokie, Illinois, United States
Site recruitment: Not reported
Investigational Site Number 8400044
Lexington, Kentucky, United States
Site recruitment: Not reported
Investigational Site Number 8400061
Boston, Massachusetts, United States
Site recruitment: Not reported
Investigational Site Number 8400001
Bridgeton, New Jersey, United States
Site recruitment: Not reported
Investigational Site Number 8400039
New Windsor, New York, United States
Site recruitment: Not reported
Investigational Site Number 8400028
Burlington, North Carolina, United States
Site recruitment: Not reported
Investigational Site Number 8400036
Morehead City, North Carolina, United States
Site recruitment: Not reported
Investigational Site Number 8400013
Maumee, Ohio, United States
Site recruitment: Not reported
Investigational Site Number 8400014
Goose Creek, South Carolina, United States
Site recruitment: Not reported
Investigational Site Number 8400030
Dallas, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400020
San Antonio, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400043
San Antonio, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400053
San Antonio, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400037
Layton, Utah, United States
Site recruitment: Not reported
Investigational Site Number 8400049
Manassas, Virginia, United States
Site recruitment: Not reported
Investigational Site Number 3480004
Budapest, Hungary
Site recruitment: Not reported
Investigational Site Number 3480003
Debrecen, Hungary
Site recruitment: Not reported
Investigational Site Number 3480001
Gyula, Hungary
Site recruitment: Not reported
Investigational Site Number 3480005
Hatvan, Hungary
Site recruitment: Not reported
Investigational Site Number 3480002
Nyíregyháza, Hungary
Site recruitment: Not reported
Investigational Site Number 6160008
Gdansk, Poland
Site recruitment: Not reported
Investigational Site Number 6160004
Gdynia, Poland
Site recruitment: Not reported
Investigational Site Number 6160010
Katowice, Poland
Site recruitment: Not reported
Investigational Site Number 6160009
Poznan, Poland
Site recruitment: Not reported
Investigational Site Number 6160003
Warsaw, Poland
Site recruitment: Not reported
Investigational Site Number 6160001
Wroclaw, Poland
Site recruitment: Not reported
Investigational Site Number 8040003
Kyiv, Ukraine
Site recruitment: Not reported
Investigational Site Number 8040001
Kyiv, Ukraine
Site recruitment: Not reported
Investigational Site Number 8040002
Kyiv, Ukraine
Site recruitment: Not reported
Investigational Site Number 8040004
Vinnytsia, Ukraine
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM

ClinicalTrials.gov · NCT04466904 · Registry updated: 2021-07-23

Condition / research focus: Type 2 Diabetes
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Countries with listed sites: China
Registry dates and results: Start: 2020-09-12. Completion: 2021-05-28 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

IBI362 (drug)
Placebo (drug)
Dulaglutide (drug)

Where the study takes place — 1 listed sites

China Japan Friendship Hospital
Beijing, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes

ClinicalTrials.gov · NCT03668470 · Registry updated: 2021-07-08

Condition / research focus: Adult Subjects With Type1Diabetes and Insulin Microsecretion
Sponsor: Hospices Civils de Lyon
Countries with listed sites: France
Registry dates and results: Start: 2019-01-31. Completion: 2021-02-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide (drug)
Placebo (drug)

Where the study takes place — 7 listed sites

Service d'Endocrinologie, Maladies Métaboliques et Nutrition, CHU Grenoble, Hopital de la Tronche
La Tronche, France
Site recruitment: Not reported
Département d''Endocrinologie, Diabétologie, Nutrition ; CHU Montpellier ; Hôpital Lapeyronie, Avenue du Doyen Giraud
Montpellier, France
Site recruitment: Not reported
Service d'Endocrinologie, Maladies Métaboliques et Nutrition,CHU Nantes,Hôpital Nord Laennec,Bd Jacques-Monod,Saint-Herblain
Nantes, France
Site recruitment: Not reported
Service de Diabétologie et Maladies Métaboliques, Assistance Publique des Hôpitaux de Paris ;Hôpital Cochin, 27 rue du Faubourg Saint-Jacques
Paris, France
Site recruitment: Not reported
Service d'Endocrinologie, Diabétologie, Maladies de la Nutrition, Hospices Civils de Lyon, Centre hospitalier Lyon-Sud
Pierre-Bénite, France
Site recruitment: Not reported
Service de Diabétologie Maladies Métaboliques et Nutrition ; CHU Toulouse, Pôle cardiovasculaire et métabolique, Hôpital Rangueil ; 1, avenue du Professeur Jean Poulhès - TSA 50032
Toulouse, France
Site recruitment: Not reported
Service de Diabétologie, Maladies Métaboliques, Nutrition ; CHU Nancy ; Technopôle Nancy-Brabois ; Rue du Morvan,
Vandœuvre-lès-Nancy, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes

ClinicalTrials.gov · NCT03015220 · Registry updated: 2021-03-02

Condition / research focus: Diabetes; Diabetes Mellitus, Type 2
Sponsor: Novo Nordisk A/S
Countries with listed sites: Japan
Registry dates and results: Start: 2017-01-10. Completion: 2018-07-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Semaglutide (drug)
Dulaglutide (drug)

Where the study takes place — 34 listed sites

Novo Nordisk Investigational Site
Adachi-ku, Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Annaka-shi, Gunma, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Arakawa-ku, Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Chiba-shi, Chiba, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Fukushima, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Gunma, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Ibaraki, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Iruma-shi, Saitama, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Kanagawa, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Kashiwara-shi, Osaka, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Kawagoe-shi, Saitama, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Kawaguchi-shi, Saitama, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Kumamoto, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Kurashiki-shi, Okayama, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Kyoto-shi, Kyoto, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Mitaka-shi, Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Mito-shi, Ibaraki, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Miyazaki, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Osaka, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Ota-ku, Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Sapporo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Sapporo-shi, Hokkaido, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Sendai-shi, Miyagi, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Shimotsuke-shi, Tochigi, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Shinagawa-ku, Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Shizuoka-shi, Shizuoka, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Suita-shi, Osaka, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Toshima-ku, Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Yamato-shi, Kanagawa, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)

ClinicalTrials.gov · NCT04143802 · Registry updated: 2021-01-20

Condition / research focus: Diabetes Mellitus, Type 2
Sponsor: Eli Lilly and Company
Countries with listed sites: United States
Registry dates and results: Start: 2019-12-18. Completion: 2020-12-28 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

LY3437943 (drug)
Dulaglutide (drug) — also listed as: LY2189265
Placebo (drug)

Where the study takes place — 4 listed sites

Anaheim Clinical Trials, LLC
Anaheim, California, United States
Site recruitment: Not reported
Miami Research Associates
Miami, Florida, United States
Site recruitment: Not reported
PRA International
Lenexa, Kansas, United States
Site recruitment: Not reported
Clinical Trials of Texas, Inc.
San Antonio, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?

ClinicalTrials.gov · NCT02846233 · Registry updated: 2020-11-10

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: University of California, San Francisco
Countries with listed sites: United States
Registry dates and results: Start: 2016-08. Completion: 2018-12 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GLP1 receptor agonist (drug) — also listed as: Albiglutide (Tanzeum) or , Dulaglutide (Trulicity)
basal insulin (drug) — also listed as: Lantus, Toujeo, NPH, levemir
SGLT2 inhibitor (drug) — also listed as: Empagliflozin (Jardiance)
Metformin (drug)

Where the study takes place — 1 listed sites

UCSF Fresno
Fresno, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus

ClinicalTrials.gov · NCT02597049 · Registry updated: 2020-06-17

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: Eli Lilly and Company
Countries with listed sites: Austria · Czechia · Germany · Hungary · Israel · Mexico · Puerto Rico · Spain · United States
Registry dates and results: Start: 2015-11. Completion: 2017-02 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide (drug) — also listed as: LY2189265
Placebo (drug)
SGLT2 inhibitor (drug) — also listed as: Canagliflozin, Dapagliflozin, Empagliflozin
Metformin (drug)

Where the study takes place — 41 listed sites

Medical Group of Encino
Encino, California, United States
Site recruitment: Not reported
National Research Institute
Huntington Park, California, United States
Site recruitment: Not reported
National Research Institute
Los Angeles, California, United States
Site recruitment: Not reported
New Horizon Research Center
Miami, Florida, United States
Site recruitment: Not reported
Metabolic Research Institute Inc.
West Palm Beach, Florida, United States
Site recruitment: Not reported
Cotton O'Neil Diabetes and Endocrinology Center
Topeka, Kansas, United States
Site recruitment: Not reported
JCMG Clinical Research
Jefferson City, Missouri, United States
Site recruitment: Not reported
Grand Street Medical PC
Brooklyn, New York, United States
Site recruitment: Not reported
Diabetes & Endocrinology Consultants PC
Morehead City, North Carolina, United States
Site recruitment: Not reported
PMG Research of Wilmington, LLC
Wilmington, North Carolina, United States
Site recruitment: Not reported
Dallas Diabetes Endocrine Center
Dallas, Texas, United States
Site recruitment: Not reported
Galenos Research
Dallas, Texas, United States
Site recruitment: Not reported
Endeavor Clinical Trials
San Antonio, Texas, United States
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Saint Stefan Ob Stainz, Austria
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Steyr, Austria
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Vienna, Austria
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Brandys Nad Labem-Stara Bolesl, Czechia
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Holešov, Czechia
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Krnov, Czechia
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Pardubice, Czechia
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Prague, Czechia
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Prague, Czechia
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Münster, Germany
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Oldenburg, Germany
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Budapest, Hungary
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Budapest, Hungary
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Debrecen, Hungary
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Nagykanizsa, Hungary
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Haifa, Israel
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Holon, Israel
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Jerusalem, Israel
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Monterrey, Mexico
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Monterrey, Mexico
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Zapopan, Mexico
Site recruitment: Not reported
Centro de Endocrinologia y Nutricion
Caguas, Puerto Rico
Site recruitment: Not reported
Manati Medical Center
Manati, Puerto Rico
Site recruitment: Not reported
Centro de Endocrinologia del Este
Yabucoa, Puerto Rico
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Alicante, Spain
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Málaga, Spain
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Seville, Spain
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Seville, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

ClinicalTrials.gov · NCT03495102 · Registry updated: 2020-06-12

Condition / research focus: Diabetes Mellitus, Type 2
Sponsor: Eli Lilly and Company
Countries with listed sites: Argentina · Austria · Canada · Greece · Hungary · Israel · Italy · Mexico · Poland · Puerto Rico · Romania · Russia · Slovakia · Spain · Taiwan · United States
Registry dates and results: Start: 2018-04-05. Completion: 2019-10-10 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide (drug) — also listed as: LY2189265

Where the study takes place — 208 listed sites

Synexus- Chandler
Chandler, Arizona, United States
Site recruitment: Not reported
Synexus/Central Arizona Medical Associates, PC
Mesa, Arizona, United States
Site recruitment: Not reported
Central Phoenix Med Clinic LLC
Phoenix, Arizona, United States
Site recruitment: Not reported
Arkansas Clinical Research
Little Rock, Arkansas, United States
Site recruitment: Not reported
Anaheim Clinical Trials, LLC
Anaheim, California, United States
Site recruitment: Not reported
Valley Research
Fresno, California, United States
Site recruitment: Not reported
National Research Institute
Huntington Park, California, United States
Site recruitment: Not reported
National Research Institute
Los Angeles, California, United States
Site recruitment: Not reported
Catalina Research Institute, LLC
Montclair, California, United States
Site recruitment: Not reported
Valley Clinical Trials, Inc.
Northridge, California, United States
Site recruitment: Not reported
Pacific Research Partners, LLC
Oakland, California, United States
Site recruitment: Not reported
National Research Institute
Panorama City, California, United States
Site recruitment: Not reported
Sierra Clinical Research
Roseville, California, United States
Site recruitment: Not reported
Artemis Institute for Clinical Research
San Diego, California, United States
Site recruitment: Not reported
Care Access Research
Santa Clarita, California, United States
Site recruitment: Not reported
Encompass Clinical Research
Spring Valley, California, United States
Site recruitment: Not reported
University Clinical Investigators, Inc.
Tustin, California, United States
Site recruitment: Not reported
Diablo Clinical Research
Walnut Creek, California, United States
Site recruitment: Not reported
Chase Medical Research, LLC
Waterbury, Connecticut, United States
Site recruitment: Not reported
ALL Medical Research, LLC
Cooper City, Florida, United States
Site recruitment: Not reported
Clinical Research of South Florida
Coral Gables, Florida, United States
Site recruitment: Not reported
Suncoast Research Group, LLC
Miami, Florida, United States
Site recruitment: Not reported
New Horizon Research Center
Miami, Florida, United States
Site recruitment: Not reported
Oviedo Medical Research
Oviedo, Florida, United States
Site recruitment: Not reported
Urban Family Practice Associates, PC
Marietta, Georgia, United States
Site recruitment: Not reported
In-Quest Medical Research, LLC- Peachtree Corners
Peachtree Corners, Georgia, United States
Site recruitment: Not reported
Pacific Diabetes & Endocrine Center
Honolulu, Hawaii, United States
Site recruitment: Not reported
East West Medical Institute
Honolulu, Hawaii, United States
Site recruitment: Not reported
Elite Clinical Trials LLLP
Blackfoot, Idaho, United States
Site recruitment: Not reported
Saltzer Medical Group. P.A.
Nampa, Idaho, United States
Site recruitment: Not reported
Prairie Education and Research Cooperative
Springfield, Illinois, United States
Site recruitment: Not reported
Synexus/Clinical Research Advantage
Evansville, Indiana, United States
Site recruitment: Not reported
Midwest Institute for Clinical Research
Indianapolis, Indiana, United States
Site recruitment: Not reported
Iderc, P.L.C.
West Des Moines, Iowa, United States
Site recruitment: Not reported
InterMed, PA
Portland, Maine, United States
Site recruitment: Not reported
MedStar Health Research Institute
Hyattsville, Maryland, United States
Site recruitment: Not reported
NECCR PrimaCare Research, LLC
Fall River, Massachusetts, United States
Site recruitment: Not reported
Aa Mrc Llc
Flint, Michigan, United States
Site recruitment: Not reported
Troy Internal Medicine, PC
Troy, Michigan, United States
Site recruitment: Not reported
Clinical Research Professionals
Chesterfield, Missouri, United States
Site recruitment: Not reported
StudyMetrix Research, LLC
City of Saint Peters, Missouri, United States
Site recruitment: Not reported
Montana Health Research
Billings, Montana, United States
Site recruitment: Not reported
Glacier View Research Institute
Kalispell, Montana, United States
Site recruitment: Not reported
Premier Research
Trenton, New Jersey, United States
Site recruitment: Not reported
Manhattan Medical Research
New York, New York, United States
Site recruitment: Not reported
Great Lakes Medical Research
Westfield, New York, United States
Site recruitment: Not reported
Metrolina Internal Medicine, P.A.
Charlotte, North Carolina, United States
Site recruitment: Not reported
Diabetes & Endocrinology Consultants PC
Morehead City, North Carolina, United States
Site recruitment: Not reported
Aventiv Research
Columbus, Ohio, United States
Site recruitment: Not reported
Intend Research
Norman, Oklahoma, United States
Site recruitment: Not reported
IPS Research Company
Oklahoma City, Oklahoma, United States
Site recruitment: Not reported
The Corvallis Clinic P.C.
Corvallis, Oregon, United States
Site recruitment: Not reported
Summit Research Network Inc
Portland, Oregon, United States
Site recruitment: Not reported
Heritage Valley Medical Group, Inc.
Beaver, Pennsylvania, United States
Site recruitment: Not reported
Detweiler Family Medicine
Lansdale, Pennsylvania, United States
Site recruitment: Not reported
Preferred Primary Care Physicians
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
Sudir Bansal M.D. Inc.
Warwick, Rhode Island, United States
Site recruitment: Not reported
PMG Research of Charleston, LLC
Moncks Corner, South Carolina, United States
Site recruitment: Not reported
Chattanooga Research and Medicine (CHARM)
Chattanooga, Tennessee, United States
Site recruitment: Not reported
Dallas Diabetes Endocrine Center
Dallas, Texas, United States
Site recruitment: Not reported
Southern Endocrinology and Associates PA
Mesquite, Texas, United States
Site recruitment: Not reported
Consano Clinical Research
Shavano Park, Texas, United States
Site recruitment: Not reported
Martin Diagnostic Clinic
Tomball, Texas, United States
Site recruitment: Not reported
ClinPoint Trials, LLC
Waxahachie, Texas, United States
Site recruitment: Not reported
Progressive Clinical Research
Bountiful, Utah, United States
Site recruitment: Not reported
Advanced Research Institute
Ogden, Utah, United States
Site recruitment: Not reported
Manassas Clinical Research Center
Manassas, Virginia, United States
Site recruitment: Not reported
Clinical Research Partners, LLC
Richmond, Virginia, United States
Site recruitment: Not reported
Capital Clincial Research Center
Olympia, Washington, United States
Site recruitment: Not reported
Walla Walla Clinic
Walla Walla, Washington, United States
Site recruitment: Not reported
Wenatchee Valley Hospital & Clinics
Wenatchee, Washington, United States
Site recruitment: Not reported
Prevea Clinic, Inc
Green Bay, Wisconsin, United States
Site recruitment: Not reported
Centro Medico CICEMO
Caba, Buenos Aires, Argentina
Site recruitment: Not reported
CEDIC-Centro de Investigaciones Clinicas
Caba, Buenos Aires, Argentina
Site recruitment: Not reported
Investigaciones Medicas IMOBA S.R.L.
Caba, Buenos Aires, Argentina
Site recruitment: Not reported
Centro de Investigaciones Metabólicas (CINME)
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
Site recruitment: Not reported
Centro Medico Dr Laura Maffei Investigacion Clinica Aplicada
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
Site recruitment: Not reported
Centro de Investigacion y Prevencion Cardiovascular (CIPREC)
Ciudad Autonoma de, Buenos Aires, Argentina
Site recruitment: Not reported
Instituto de Investigaciones Clinicas Mar del Plata
Mar del Plata, Buenos Aires, Argentina
Site recruitment: Not reported
CIPADI
Godoy Cruz, Mendoza Province, Argentina
Site recruitment: Not reported
AXISMED SRL - Bioclinica Research Network
Buenos Aires, Argentina
Site recruitment: Not reported
CENUDIAB
Ciudad Autonoma de Buenos Aire, Argentina
Site recruitment: Not reported
Centro Médico Viamonte
Ciudad Autonoma de Buenos Aire, Argentina
Site recruitment: Not reported
Instituto Centenario
Ciudad Autonoma de Buenos Aire, Argentina
Site recruitment: Not reported
Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff
Ciudad Autonoma de Buenos Aire, Argentina
Site recruitment: Not reported
Mautalen Salud e Investigación - Servicio de Endocrinología
Ciudad Autonoma de Buenos Air, Argentina
Site recruitment: Not reported
Instituto Medico Strusberg
Córdoba, Argentina
Site recruitment: Not reported
Centro Medico Privado San Vicente Diabetes
Córdoba, Argentina
Site recruitment: Not reported
Cent Priva Especiali Médicas Ambulatorias Inve Clin CEMAIC
Córdoba, Argentina
Site recruitment: Not reported
Landesklinikum Korneuburg-Stockerau, Standort Stockerau
Stockerau, Lower Austria, Austria
Site recruitment: Not reported
Universitätsklinikum Graz
Graz, Styria, Austria
Site recruitment: Not reported
Ordination Dr. Evelyn Fließer-Görzer
Saint Stefan Ob Stainz, Styria, Austria
Site recruitment: Not reported
VIVIT Institut am LKH Feldkirch
Feldkirch, Vorarlberg, Austria
Site recruitment: Not reported
KA Rudolfstiftung
Vienna, Austria
Site recruitment: Not reported
Zentrum für klinische Studien Dr. Ursula Hanusch GmbH
Vienna, Austria
Site recruitment: Not reported
Bailey Clinic
Red Deer, Alberta, Canada
Site recruitment: Not reported
Aggarwal and Associates Ltd
Brampton, Ontario, Canada
Site recruitment: Not reported
T. Nemtean Medicine Professional Corporation
Mississauga, Ontario, Canada
Site recruitment: Not reported
Bluewater Clinical Research Group Inc
Sarnia, Ontario, Canada
Site recruitment: Not reported
Stayner Medical Clinic
Stayner, Ontario, Canada
Site recruitment: Not reported
Dr. Anil K. Gupta Medicine Professional Corporation
Toronto, Ontario, Canada
Site recruitment: Not reported
Iatriko Palaiou Falirou, Medical Center
Palaió Fáliro, Athens, Greece
Site recruitment: Not reported
Laiko General Hospital of Athens
Ampelokipoi, Attica, Greece
Site recruitment: Not reported
Gen Hospital of Athens G Gennimatas
Athens, Attica, Greece
Site recruitment: Not reported
G.Papanikolaou General Hospital
Eksochi, Thessaloniki, Greece
Site recruitment: Not reported
Thermi Clinic
Thermi, Thessaloniki, Greece
Site recruitment: Not reported
Athens Euroclinic
Athens, Greece
Site recruitment: Not reported
University General Hospital of Larissa
Larissa, Greece
Site recruitment: Not reported
AHEPA Hospital
Thessaloniki, Greece
Site recruitment: Not reported
Ippokrateio General Hospital of Thessaloniki
Thessaloniki, Greece
Site recruitment: Not reported
Euromedica - General Clinic of Thessaloniki
Thessaloniki, Greece
Site recruitment: Not reported
Studium Egeszseghaz Kft.
Kalocsa, Bács-Kiskun county, Hungary
Site recruitment: Not reported
Kenezy Gyula Korhaz es Rendelointezet
Debrecen, Hajdú-Bihar, Hungary
Site recruitment: Not reported
Grof Esterhazy Korhaz es Rendelointezeti Szakrendelo
Pápa, Veszprém megye, Hungary
Site recruitment: Not reported
Szent Margit Rendelointezet
Budapest, Hungary
Site recruitment: Not reported
ClinDiab Kft.
Budapest, Hungary
Site recruitment: Not reported
Strazsahegy Medicina Bt.
Budapest, Hungary
Site recruitment: Not reported
TRANTOR 99 Bt.
Budapest, Hungary
Site recruitment: Not reported
Kanizsai Dorottya Korhaz
Nagykanizsa, Hungary
Site recruitment: Not reported
Zala Megyei Szent Rafael Korhaz
Zalaegerszeg, Hungary
Site recruitment: Not reported
Maccabi Diabetes Clinic, Grand Canyon, North District, Haifa
Haifa, Israel
Site recruitment: Not reported
Linn Medical Center
Haifa, Israel
Site recruitment: Not reported
Hadassah Medical Center
Jerusalem, Israel
Site recruitment: Not reported
Meir Medical Center
Kfar Saba, Israel
Site recruitment: Not reported
Clalit Health Services - Shuali Clinic
Raanana, Israel
Site recruitment: Not reported
ZIV Medical Center
Safed, Israel
Site recruitment: Not reported
Sakhnin Community Clinic, Clalit Health Services
Sakhnin, Israel
Site recruitment: Not reported
Diabetes Medical Center (DMC)
Tel Aviv, Israel
Site recruitment: Not reported
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Site recruitment: Not reported
Azienda Ospedaliera Universitaria Careggi
Florence, Florence, Italy
Site recruitment: Not reported
Istituto Clinico Humanitas
Rozzano, Milano, Italy
Site recruitment: Not reported
A.O.U. Senese Policlinico Santa Maria alle Scotte
Siena, SI, Italy
Site recruitment: Not reported
Azienda Ospedaliera Papa Giovanni XXIII
Bergamo, Italy
Site recruitment: Not reported
Policlinico Mater Domini
Catanzaro, Italy
Site recruitment: Not reported
Fondazione Universitaria degli Studi G D'Annunzio
Chieti, Italy
Site recruitment: Not reported
Ospedale Santa Maria Goretti
Latina, Italy
Site recruitment: Not reported
Policlinico Giaccone
Palermo, Italy
Site recruitment: Not reported
Ospedale Civile Maggiore Borgo Trento
Verona, Italy
Site recruitment: Not reported
Hospital Univ. Dr. Jose Eleuterio Gonzalez
Monterrey, Nuevo León, Mexico
Site recruitment: Not reported
Investigacion en Salud y Metabolismo S.C
Chihuahua City, Mexico
Site recruitment: Not reported
NZOZ ZDROWIE Osteo-Medic
Bialystok, Poland
Site recruitment: Not reported
Poradnia Diabetologiczna SN ZOZ Lege Artis
Bialystok, Poland
Site recruitment: Not reported
NS ZOZ Osrodek Diabetologiczny " Popula"
Bialystok, Poland
Site recruitment: Not reported
Centrum Badan Klinicznych, PI House
Gdansk, Poland
Site recruitment: Not reported
NZOZ Salvia s.c.
Katowice, Poland
Site recruitment: Not reported
NZOZ Diab-Endo-Met
Krakow, Poland
Site recruitment: Not reported
Centrum Terapii Wspolczesnej J.M. Jasnorzewska S.K.A.
Lodz, Poland
Site recruitment: Not reported
Gabinety Terpa
Lublin, Poland
Site recruitment: Not reported
NZOZ Przychodnia Specjalistyczna MEDICA
Lublin, Poland
Site recruitment: Not reported
Centrum Medyczne OMEDICA
Poznan, Poland
Site recruitment: Not reported
Praktyka Lekarska
Poznan, Poland
Site recruitment: Not reported
Nzoz Neuro - Kard
Poznan, Poland
Site recruitment: Not reported
NZOZ Przychodnia Specjalistyczna Henryk RudzkiAndrzej Wittek
Ruda Śląska, Poland
Site recruitment: Not reported
Centralny Szpital Kliniczny MSW
Warsaw, Poland
Site recruitment: Not reported
Regionalna Poradnia Diabetologiczna
Wroclaw, Poland
Site recruitment: Not reported
Research and Cardiovascular Corp.
Ponce, PR, Puerto Rico
Site recruitment: Not reported
Office: Dr. Luis Rivera Colon
San Juan, PR, Puerto Rico
Site recruitment: Not reported
Clinical Research Puerto Rico, Inc.
San Juan, Puerto Rico
Site recruitment: Not reported
GCM Medical Group PSC
San Juan, Puerto Rico
Site recruitment: Not reported
S. C. Grandmed S.R.L., Str.
Oradea, Bihor County, Romania
Site recruitment: Not reported
SC Gama Diamed SRL
Mangalia, Constanța County, Romania
Site recruitment: Not reported
Spitalul Judetean de Urgenta Satu Mare
Satu Mare, Jud Satu-Mare, Romania
Site recruitment: Not reported
CMI DNBM Dr. Pop Lavinia
Baia Mare, Maramureş, Romania
Site recruitment: Not reported
Cosamext SRL
Târgu Mureş, Mureș County, Romania
Site recruitment: Not reported
SC Diabmed Dr Popescu Alexandrina SRL
Ploieşti, Prahova, Romania
Site recruitment: Not reported
SC Dianutrilife Medica SRL
Ploieşti, Prahova, Romania
Site recruitment: Not reported
Centrul Medical Dr. Negrisanu
Timișoara, Timiș County, Romania
Site recruitment: Not reported
Centrul Medical de Diagnostic si Tratament Ambulatoriu Neomed SRL
Brasov, Romania
Site recruitment: Not reported
Cabinetul Medical Nicodiab SRL
Bucharest, Romania
Site recruitment: Not reported
Easydiet SRL
Bucharest, Romania
Site recruitment: Not reported
SC Nutrilife SRL
Bucharest, Romania
Site recruitment: Not reported
SC Medcon SRL
Buzău, Romania
Site recruitment: Not reported
Centrul Medical Unirea SRL
Cluj-Napoca, Romania
Site recruitment: Not reported
Cabinet Medical Urodiamed S.R.L.
Craiova, Romania
Site recruitment: Not reported
Milena Sante SRL
Galati, Romania
Site recruitment: Not reported
SC Olimpia Med SRL
Iași, Romania
Site recruitment: Not reported
Regional Clinical Hospital
Saratov, Russian Federation, Russia
Site recruitment: Not reported
Arkhangelsk Regional Clinical Hospital
Arkhangelsk, Russia
Site recruitment: Not reported
Arkhangelsk the first city clinical hospital
Arkhangelsk, Russia
Site recruitment: Not reported
Rostov State Medical University
Rostov-on-Don, Russia
Site recruitment: Not reported
City Hospital of Saint Martyr Elizabeth
Saint Petersburg, Russia
Site recruitment: Not reported
SPb GUZ "Diagnostic Center #85"
Saint Petersburg, Russia
Site recruitment: Not reported
Human care s.r.o.
Košice, Slovak Republic, Slovakia
Site recruitment: Not reported
MediVet s.r.o.
Malacky, Slovak Republic, Slovakia
Site recruitment: Not reported
Areteus s.r.o.
Trebišov, Slovak Republic, Slovakia
Site recruitment: Not reported
Diacrin s.r.o.
Bratislava, Slovakia
Site recruitment: Not reported
Noemis, s.r.o.
Nové Mesto nad Váhom, Slovakia
Site recruitment: Not reported
FUNKYSTUFF s.r.o.
Nové Zámky, Slovakia
Site recruitment: Not reported
MUDr. Jan Culak, s.r.o.
Prievidza, Slovakia
Site recruitment: Not reported
DIA-MED CENTRUM s.r.o.
Púchov, Slovakia
Site recruitment: Not reported
Tatratrial s.r.o.
Rožňava, Slovakia
Site recruitment: Not reported
Hospital Infanta Luisa
Seville, Andalusia, Spain
Site recruitment: Not reported
Clinica Juaneda
Palma de Mallorca, Balearic Islands, Spain
Site recruitment: Not reported
Corporació Sanitaria Parc Tauli
Sabadell, Barcelona, Spain
Site recruitment: Not reported
Hospital Universitario Marques De Valdecilla
Santander, Cantabria, Spain
Site recruitment: Not reported
Hospital Universitario Quiron Madrid
Pozuelo de Alarcón, Madrid, Spain
Site recruitment: Not reported
Instituto de Ciencias medicas
Alicante, Spain
Site recruitment: Not reported
Clinica San Pedro
Almería, Spain
Site recruitment: Not reported
Centre Medico Teknon
Barcelona, Spain
Site recruitment: Not reported
Hospital Clinico Universitario San Cecilio
Granada, Spain
Site recruitment: Not reported
Virgen de Las Nieves
Granada, Spain
Site recruitment: Not reported
Centro Especialidades San Jose Obrero (Barbarela)
Málaga, Spain
Site recruitment: Not reported
Clinica Nuevas Tecnologias en Diabetes y Endocrinologia
Seville, Spain
Site recruitment: Not reported
Hospital Universitario Virgen Macarena
Seville, Spain
Site recruitment: Not reported
Policlinica Galileo
Teruel, Spain
Site recruitment: Not reported
Chung Shan Medical University Hospital
Taichung, Taiwan
Site recruitment: Not reported
Taichung Veterans General Hospital
Taichung, Taiwan
Site recruitment: Not reported
Chi-Mei Medical Center
Tainan, Taiwan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

ClinicalTrials.gov · NCT03724981 · Registry updated: 2020-04-24

Condition / research focus: Diabetes Mellitus, Type 2
Sponsor: Eli Lilly and Company
Countries with listed sites: United States
Registry dates and results: Start: 2018-10-18. Completion: 2019-04-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide Pen (drug)
Semaglutide Pen (drug)

Where the study takes place — 14 listed sites

Valley Research
Fresno, California, United States
Site recruitment: Not reported
Long Beach Center for Clinical Research
Long Beach, California, United States
Site recruitment: Not reported
Palm Harbor Medical Associates
Palm Harbor, Florida, United States
Site recruitment: Not reported
Georgia Clinical Research
Snellville, Georgia, United States
Site recruitment: Not reported
Cedar-Crosse Research Center
Chicago, Illinois, United States
Site recruitment: Not reported
L-Marc Research Center
Louisville, Kentucky, United States
Site recruitment: Not reported
Evidera
Bethesda, Maryland, United States
Site recruitment: Not reported
Carolina Research Center, Inc.
Shelby, North Carolina, United States
Site recruitment: Not reported
Lillestol Research LLC
Fargo, North Dakota, United States
Site recruitment: Not reported
BRCR Medical Center, Inc.
Camp Hill, Pennsylvania, United States
Site recruitment: Not reported
Juno Research
Houston, Texas, United States
Site recruitment: Not reported
Juno Research, LLC
Houston, Texas, United States
Site recruitment: Not reported
PI-Coor Clinical Research, LLC
Annandale, Virginia, United States
Site recruitment: Not reported
Manassas Clinical Research Center
Manassas, Virginia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes

ClinicalTrials.gov · NCT03444142 · Registry updated: 2020-03-26

Condition / research focus: Diabetes Mellitus, Type 2
Sponsor: University of Guadalajara
Countries with listed sites: Mexico
Registry dates and results: Start: 2017-11-17. Completion: 2021-11-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Exenatide LAR (drug) — also listed as: Bydureon
Dulaglutide (drug) — also listed as: Trulicity

Where the study takes place — 1 listed sites

Instituto de terapeutica Experimental y Clinica. Centro universitario de Ciencias de la Salud. Universidad de Guadalajara
Guadalajara, Jalisco, Mexico
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists

ClinicalTrials.gov · NCT04184947 · Registry updated: 2020-03-11

Condition / research focus: Type 2 Diabetes
Sponsor: University of Padova
Countries with listed sites: Italy
Registry dates and results: Start: 2014-03-01. Completion: 2020-02-29 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

SGLT2 inhibitor (drug)
GLP-1 receptor agonist (drug)

Where the study takes place — 1 listed sites

Division of Metabolic Diseases, University Hospital of Padova
Padova, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

ClinicalTrials.gov · NCT03590626 · Registry updated: 2020-02-20

Condition / research focus: Non Alcoholic Fatty Liver Disease; Type2 Diabetes Mellitus
Sponsor: Medanta, The Medicity, India
Countries with listed sites: India
Registry dates and results: Start: 2019-01-01. Completion: 2020-02-18 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide (drug)

Where the study takes place — 1 listed sites

Division Of Endocrinology & Diabetes, Medanta The Medicity
Gurgaon, Haryana, India
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)

ClinicalTrials.gov · NCT02770885 · Registry updated: 2020-01-18

Condition / research focus: Primary Polydipsia
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2016-03. Completion: 2019-10-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide (drug) — also listed as: Trulicity
Placebo (drug) — also listed as: Sodium Chloride 0.9%

Where the study takes place — 1 listed sites

University Hospital Basel
Basel, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-10-07 20:57 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3CompletedINTERVENTIONAL

A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes

ClinicalTrials.gov · NCT02963766 · Registry updated: 2022-07-01

Condition / research focus: Type 2 Diabetes
Sponsor: Eli Lilly and Company
Countries with listed sites: Brazil · France · Germany · Hungary · India · Mexico · Puerto Rico · Saudi Arabia · Turkey (Türkiye) · United Kingdom · United States
Registry dates and results: Start: 2016-12-29. Completion: 2022-01-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide (drug) — also listed as: LY2189265
Placebo (drug)

Where the study takes place — 61 listed sites

University of Alabama Birmingham
Birmingham, Alabama, United States
Site recruitment: Not reported
University of Arizona
Tucson, Arizona, United States
Site recruitment: Not reported
Advanced Research Center
Anaheim, California, United States
Site recruitment: Not reported
Division of Endocrinology, Diabetes, and Metabolism
Los Angeles, California, United States
Site recruitment: Not reported
Childrens Hospital of Orange County
Orange, California, United States
Site recruitment: Not reported
Center of Excellence in Diabetes & Endocrinology
Sacramento, California, United States
Site recruitment: Not reported
Rady Childrens Hospital - San Diego
San Diego, California, United States
Site recruitment: Not reported
JC Cabaccan
San Jose, California, United States
Site recruitment: Not reported
Touro University
Vallejo, California, United States
Site recruitment: Not reported
Children's National Medical Center
Washington D.C., District of Columbia, United States
Site recruitment: Not reported
Florida Center for Endocrinology & Metabolism
Orlando, Florida, United States
Site recruitment: Not reported
St. Luke's Regional Medical Center
Boise, Idaho, United States
Site recruitment: Not reported
University of Illinois at Chicago
Chicago, Illinois, United States
Site recruitment: Not reported
Indiana University Health Hospital
Indianapolis, Indiana, United States
Site recruitment: Not reported
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Site recruitment: Not reported
Children's Mercy Hospital
Kansas City, Missouri, United States
Site recruitment: Not reported
ECU Pediatric Specialty Care
Greenville, North Carolina, United States
Site recruitment: Not reported
Cincinnati Childrens Hospital Medical Center
Cincinnati, Ohio, United States
Site recruitment: Not reported
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Childrens Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
Seattle Children's Hospital Research Foundation
Seattle, Washington, United States
Site recruitment: Not reported
Multicare Health System
Tacoma, Washington, United States
Site recruitment: Not reported
CAMC Institute
Charleston, West Virginia, United States
Site recruitment: Not reported
Instituto Estadual de Diabetes e Endocrinologia
Rio de Janeiro, Rio de Janeiro, Brazil
Site recruitment: Not reported
Centro de Pesquisas em Diabetes
Porto Alegre, Rio Grande do Sul, Brazil
Site recruitment: Not reported
Instituto da Criança com Diabetes
Porto Alegre, Rio Grande do Sul, Brazil
Site recruitment: Not reported
Hospital PUC-CAMPINAS
Campinas, São Paulo, Brazil
Site recruitment: Not reported
Hospital das Clinicas da FMRP
Ribeirão Preto, São Paulo, Brazil
Site recruitment: Not reported
CPCLIN
São Paulo, São Paulo, Brazil
Site recruitment: Not reported
Hospital da Clinicas da Faculdade de Medicina da USP
São Paulo, São Paulo, Brazil
Site recruitment: Not reported
UNIFESP - Escola Paulista de Medicina
São Paulo, Brazil
Site recruitment: Not reported
Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre
Le Kremlin-Bicêtre, France
Site recruitment: Not reported
Hopital Robert Debre
Paris, France
Site recruitment: Not reported
Praxis Dr. med. Landers
Mayen, Rhineland-Palatinate, Germany
Site recruitment: Not reported
Zentrum für klinische Studien
Sankt Ingbert, Saarland, Germany
Site recruitment: Not reported
RED-Institut GmbH
Oldenburg in Holstein, Schleswig-Holstein, Germany
Site recruitment: Not reported
Heim Pal Gyermekkorhaz
Budapest, Hungary
Site recruitment: Not reported
Dr Jivraj Mehta Smarak Health Foundation Bakeri Medical Research Centre
Ahmedabad, Gujarat, India
Site recruitment: Not reported
Manipal Hospital
Bangalore, Karmnataka, India
Site recruitment: Not reported
M S Ramaiah Medical College Hospital
Bangalore, Karnataka, India
Site recruitment: Not reported
Deenanath Mangeshkar Hospital & Research Centre
Pune, Maharashtra, India
Site recruitment: Not reported
Sir Ganga Ram Hospital
New Delhi, National Capital Territory of Delhi, India
Site recruitment: Not reported
Post Graduate Institute of Medical Education & Research
Chandigarh, Punjab, India
Site recruitment: Not reported
Banaras Hindu University - BHU
Varanasi, Uttar Pradesh, India
Site recruitment: Not reported
Park Clinic
Kolkata, West Bengal, India
Site recruitment: Not reported
Apollo Gleneagles Hospitals Kolkata
Kolkata, West Bengal, India
Site recruitment: Not reported
Health Pharma Professional Research, S.A. de C.V.
Mexico City, Federal District, Mexico
Site recruitment: Not reported
Centro de Inv. Medica de Occidente, SC
Zapopan, Jalisco, Mexico
Site recruitment: Not reported
Centro Medico San Francisco
Monterrey, Nuevo León, Mexico
Site recruitment: Not reported
Cli-nica Hospital Cemain
Tampico, Tamaulipas, Mexico
Site recruitment: Not reported
Hospital Angeles Puebla
Puebla City, Mexico
Site recruitment: Not reported
Arke Estudios Clinicos S.A. de C.V.
Veracruz, Mexico
Site recruitment: Not reported
Centro de Diabetes y Endocrinologia Pediatrica de PR
Bayamón, PR, Puerto Rico
Site recruitment: Not reported
King Saud University Hospital
Riyadh, Saudi Arabia
Site recruitment: Not reported
King Salman bin Abdulaziz Hospital - Diabetic Center
Riyadh, Saudi Arabia
Site recruitment: Not reported
Ankara University Medicine Hospital
Ankara, Mamak, Turkey (Türkiye)
Site recruitment: Not reported
Sami Ulus Education & Research Hospital
Ankara, Turkey (Türkiye)
Site recruitment: Not reported
Duzce University Medical Faculty
Düzce, Turkey (Türkiye)
Site recruitment: Not reported
Ondokuz Mayis University Medical Faculty
Samsun, Turkey (Türkiye)
Site recruitment: Not reported
Alder Hey Children's Hospital
Liverpool, Lancashire, United Kingdom
Site recruitment: Not reported
St James's University Hospital
Leeds, West Yorkshire, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

A Study of TG103 Injection in Type 2 Diabetes Subjects

ClinicalTrials.gov · NCT05348122 · Registry updated: 2022-06-13

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Countries with listed sites: China
Registry dates and results: Start: 2022-06-15. Completion: 2023-11-01 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

TG103,Q2W (drug) — also listed as: TG103 injection, subcutaneous injection,Q2W
TG103,QW (drug) — also listed as: TG103 injection, subcutaneous injection,QW
Placebo,Q2W (drug) — also listed as: Placebo, subcutaneous injection,Q2W
Placebo,QW (drug) — also listed as: Placebo, subcutaneous injection,QW
Dulaglutide,QW (drug) — also listed as: Dulaglutide,subcutaneous injection,QW

Where the study takes place — 1 listed sites

Gao Huanhuan
Shijiazhuang, Hebei, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes

ClinicalTrials.gov · NCT03861052 · Registry updated: 2022-04-14

Condition / research focus: Type 2 Diabetes
Sponsor: Eli Lilly and Company
Countries with listed sites: Japan
Registry dates and results: Start: 2019-05-07. Completion: 2021-03-31 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176
Dulaglutide (drug) — also listed as: LY2189265

Where the study takes place — 46 listed sites

Akaicho Clinic
Chiba, Chiba, Japan
Site recruitment: Not reported
Medical corporation THY Tokuyama Clinic
Chiba Mihama-ku, Chiba, Japan
Site recruitment: Not reported
National Hospital Organization Kure Medical Center
Kure, Hiroshima, Japan
Site recruitment: Not reported
Hasegawa Medical Clinic
Chitose, Hokkaido, Japan
Site recruitment: Not reported
Yuri Ono Clinic
Sapporo, Hokkaido, Japan
Site recruitment: Not reported
Watanabe Naika Clinic
Nishinomiya, Hyōgo, Japan
Site recruitment: Not reported
Hayashi Clinic
Nishinomiya, Hyōgo, Japan
Site recruitment: Not reported
Naka Memorial Clinic
Naka, Ibaraki, Japan
Site recruitment: Not reported
Hayashi Diabetes Internal Medicine Clinic
Chigasaki-sh, Kanagawa, Japan
Site recruitment: Not reported
Matoba Diabetes Clinic
Ebina, Kanagawa, Japan
Site recruitment: Not reported
Takai Naika Clinic
Kamakura, Kanagawa, Japan
Site recruitment: Not reported
Kanto Rosai Hospital
Kawasaki, Kanagawa, Japan
Site recruitment: Not reported
H.E.C. Science Clinic
Yokohama, Kanagawa, Japan
Site recruitment: Not reported
Medical Corporation Heishinkai OCROM Clinic
Suita-shi, Osaka, Japan
Site recruitment: Not reported
Takatsuki Red Cross Hospital
Takatsuki, Osaka, Japan
Site recruitment: Not reported
Senrichuo Ekimae Clinic
Toyonaka, Osaka, Japan
Site recruitment: Not reported
Asano Clinic
Kawagoe, Saitama, Japan
Site recruitment: Not reported
Kawaguchi General Hospital
Kawaguchi, Saitama, Japan
Site recruitment: Not reported
Wakakusa Clinic
Shimotsuke, Tochigi, Japan
Site recruitment: Not reported
Seiwa Clinic
Adachi-ku, Tokyo, Japan
Site recruitment: Not reported
HDC Atlas Clinic
Chiyoda City, Tokyo, Japan
Site recruitment: Not reported
Meiwa Hospital
Chiyodaku, Tokyo, Japan
Site recruitment: Not reported
Asahi Life Foundation Adult Disease Research Center
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Nihonbashi Sakura Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Tokyo-Eki Center-building Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Medical Corporation Chiseikai Tokyo Center Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Tokyo aSBo Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Fukuwa Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
IHL Shinagawa East One Medical Clinic
Minato-ku, Tokyo, Japan
Site recruitment: Not reported
Sato Medical Clinic
Ootaku, Tokyo, Japan
Site recruitment: Not reported
Shinjuku Research Park Clinic
Shinjuku, Tokyo, Japan
Site recruitment: Not reported
Medical Corporation Heishinkai ToCROM Clinic
Shinjuku-ku, Tokyo, Japan
Site recruitment: Not reported
Tomonaga Clinic
Shinjuku-ku, Tokyo, Japan
Site recruitment: Not reported
Shinei Clinic
Suginami, Tokyo, Japan
Site recruitment: Not reported
Ikebukuro Metropolitan Clinic
Toshima-ku, Tokyo, Japan
Site recruitment: Not reported
Futata Tetsuhiro Clinic
Fukuoka, Japan
Site recruitment: Not reported
JR Hiroshima Hospital
Hiroshima, Japan
Site recruitment: Not reported
Yoshimura Clinic
Kumamoto, Japan
Site recruitment: Not reported
Keiseikai Kajiyama Clinic
Kyoto, Japan
Site recruitment: Not reported
OKAYAMA Medical Center
Okayama, Japan
Site recruitment: Not reported
AMC Nishiumeda Clinic
Osaka, Japan
Site recruitment: Not reported
Kitada Clinic
Osaka, Japan
Site recruitment: Not reported
Nanko Clinic
Osaka, Japan
Site recruitment: Not reported
Abe Clinic
Ōita, Japan
Site recruitment: Not reported
Suruga Clinic
Shizuoka, Japan
Site recruitment: Not reported
Yokohama Minoru Clinic
Yokohama, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes

ClinicalTrials.gov · NCT04374578 · Registry updated: 2022-03-31

Condition / research focus: Type 2 Diabetes
Sponsor: Shanghai Zhongshan Hospital
Countries with listed sites: China
Registry dates and results: Start: 2020-05-08. Completion: 2021-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide 1.5 MG/ML (drug)

Where the study takes place — 1 listed sites

180 Fenglin Road
Shanghai, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period

ClinicalTrials.gov · NCT02787551 · Registry updated: 2022-03-25

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: Sanofi
Countries with listed sites: Canada · Estonia · Germany · Israel · Italy · Romania · Slovakia · Spain · United States
Registry dates and results: Start: 2016-07-06. Completion: 2018-11-17 (may be estimated). Results are posted in this registry.

Products and interventions (7)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Insulin glargine/lixisenatide fixed ratio combination (drug) — also listed as: HOE901/AVE0010, Soliqua
liraglutide (drug) — also listed as: Victoza
exenatide (drug) — also listed as: Byetta
exenatide extended-release (drug) — also listed as: Bydureon
albiglutide (drug) — also listed as: Tanzeum
dulaglutide (drug) — also listed as: Trulicity
Background therapy: Oral Anti-diabetic Drug (Metformin, Pioglitazone, SGLT2 inhibitor) (drug)

Where the study takes place — 124 listed sites

Investigational Site Number 8400064
Birmingham, Alabama, United States
Site recruitment: Not reported
Investigational Site Number 8400073
Fountain Hills, Arizona, United States
Site recruitment: Not reported
Investigational Site Number 8400047
Phoenix, Arizona, United States
Site recruitment: Not reported
Investigational Site Number 8400103
Bakersfield, California, United States
Site recruitment: Not reported
Investigational Site Number 8400137
Fresno, California, United States
Site recruitment: Not reported
Investigational Site Number 8400043
Huntington Park, California, United States
Site recruitment: Not reported
Investigational Site Number 8400124
Lamont, California, United States
Site recruitment: Not reported
Investigational Site Number 8400027
Lancaster, California, United States
Site recruitment: Not reported
Investigational Site Number 8400098
Los Angeles, California, United States
Site recruitment: Not reported
Investigational Site Number 8400013
Los Angeles, California, United States
Site recruitment: Not reported
Investigational Site Number 8400042
Mission Hills, California, United States
Site recruitment: Not reported
Investigational Site Number 8400006
Northridge, California, United States
Site recruitment: Not reported
Investigational Site Number 8400021
Orange, California, United States
Site recruitment: Not reported
Investigational Site Number 8400126
Rialto, California, United States
Site recruitment: Not reported
Investigational Site Number 8400094
Santa Ana, California, United States
Site recruitment: Not reported
Investigational Site Number 8400009
Ventura, California, United States
Site recruitment: Not reported
Investigational Site Number 8400071
Denver, Colorado, United States
Site recruitment: Not reported
Investigational Site Number 8400036
Denver, Colorado, United States
Site recruitment: Not reported
Investigational Site Number 8400114
Jacksonville, Florida, United States
Site recruitment: Not reported
Investigational Site Number 8400133
Miami, Florida, United States
Site recruitment: Not reported
Investigational Site Number 8400058
Port Charlotte, Florida, United States
Site recruitment: Not reported
Investigational Site Number 8400084
Tampa, Florida, United States
Site recruitment: Not reported
Investigational Site Number 8400112
West Palm Beach, Florida, United States
Site recruitment: Not reported
Investigational Site Number 8400045
Lawrenceville, Georgia, United States
Site recruitment: Not reported
Investigational Site Number 8400096
Snellville, Georgia, United States
Site recruitment: Not reported
Investigational Site Number 8400023
Springfield, Illinois, United States
Site recruitment: Not reported
Investigational Site Number 8400049
Avon, Indiana, United States
Site recruitment: Not reported
Investigational Site Number 8400053
Avon, Indiana, United States
Site recruitment: Not reported
Investigational Site Number 8400085
Avon, Indiana, United States
Site recruitment: Not reported
Investigational Site Number 8400120
Avon, Indiana, United States
Site recruitment: Not reported
Investigational Site Number 8400041
Evansville, Indiana, United States
Site recruitment: Not reported
Investigational Site Number 8400038
Indianapolis, Indiana, United States
Site recruitment: Not reported
Investigational Site Number 8400130
Council Bluffs, Iowa, United States
Site recruitment: Not reported
Investigational Site Number 8400034
Lexington, Kentucky, United States
Site recruitment: Not reported
Investigational Site Number 8400091
Lexington, Kentucky, United States
Site recruitment: Not reported
Investigational Site Number 8400078
Marrero, Louisiana, United States
Site recruitment: Not reported
Investigational Site Number 8400032
Metairie, Louisiana, United States
Site recruitment: Not reported
Investigational Site Number 8400088
New Orleans, Louisiana, United States
Site recruitment: Not reported
Investigational Site Number 8400033
Baltimore, Maryland, United States
Site recruitment: Not reported
Investigational Site Number 8400051
Jefferson City, Missouri, United States
Site recruitment: Not reported
Investigational Site Number 8400083
Papillion, Nebraska, United States
Site recruitment: Not reported
Investigational Site Number 8400044
Henderson, Nevada, United States
Site recruitment: Not reported
Investigational Site Number 8400079
Albany, New York, United States
Site recruitment: Not reported
Investigational Site Number 8400061
New York, New York, United States
Site recruitment: Not reported
Investigational Site Number 8400123
North Massapequa, New York, United States
Site recruitment: Not reported
Investigational Site Number 8400095
Staten Island, New York, United States
Site recruitment: Not reported
Investigational Site Number 8400067
West Seneca, New York, United States
Site recruitment: Not reported
Investigational Site Number 8400111
Yonkers, New York, United States
Site recruitment: Not reported
Investigational Site Number 8400020
Morehead City, North Carolina, United States
Site recruitment: Not reported
Investigational Site Number 8400065
Wilmington, North Carolina, United States
Site recruitment: Not reported
Investigational Site Number 8400018
Fargo, North Dakota, United States
Site recruitment: Not reported
Investigational Site Number 8400019
Columbus, Ohio, United States
Site recruitment: Not reported
Investigational Site Number 8400056
Dayton, Ohio, United States
Site recruitment: Not reported
Investigational Site Number 8400125
Mentor, Ohio, United States
Site recruitment: Not reported
Investigational Site Number 8400099
Oklahoma City, Oklahoma, United States
Site recruitment: Not reported
Investigational Site Number 8400129
Scottdale, Pennsylvania, United States
Site recruitment: Not reported
Investigational Site Number 8400076
Smithfield, Pennsylvania, United States
Site recruitment: Not reported
Investigational Site Number 8400104
Warwick, Rhode Island, United States
Site recruitment: Not reported
Investigational Site Number 8400090
Columbia, South Carolina, United States
Site recruitment: Not reported
Investigational Site Number 8400139
Austin, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400001
Dallas, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400118
Edinburg, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400008
Houston, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400109
Houston, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400063
Houston, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400106
Houston, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400014
North Richland Hills, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400089
San Antonio, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400135
Schertz, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400075
Shavano Park, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400107
Sugar Land, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400054
Orem, Utah, United States
Site recruitment: Not reported
Investigational Site Number 8400025
Salt Lake City, Utah, United States
Site recruitment: Not reported
Investigational Site Number 8400092
Weber City, Virginia, United States
Site recruitment: Not reported
Investigational Site Number 1240003
Burlington, Canada
Site recruitment: Not reported
Investigational Site Number 1240006
Corunna, Canada
Site recruitment: Not reported
Investigational Site Number 1240002
Red Deer, Canada
Site recruitment: Not reported
Investigational Site Number 1240001
Vancouver, Canada
Site recruitment: Not reported
Investigational Site Number 2330002
Pärnu, Estonia
Site recruitment: Not reported
Investigational Site Number 2330003
Tallinn, Estonia
Site recruitment: Not reported
Investigational Site Number 2330001
Tallinn, Estonia
Site recruitment: Not reported
Investigational Site Number 2330004
Viljandi, Estonia
Site recruitment: Not reported
Investigational Site Number 2760001
Dresden, Germany
Site recruitment: Not reported
Investigational Site Number 2760003
Oldenburg in Holstein, Germany
Site recruitment: Not reported
Investigational Site Number 3760001
Haifa, Israel
Site recruitment: Not reported
Investigational Site Number 3760002
Haifa, Israel
Site recruitment: Not reported
Investigational Site Number 3760005
Jerusalem, Israel
Site recruitment: Not reported
Investigational Site Number 3760006
Jerusalem, Israel
Site recruitment: Not reported
Investigational Site Number 3760004
Tel Aviv, Israel
Site recruitment: Not reported
Investigational Site Number 3800008
Bergamo, Italy
Site recruitment: Not reported
Investigational Site Number 3800002
Bologna, Italy
Site recruitment: Not reported
Investigational Site Number 3800001
Milan, Italy
Site recruitment: Not reported
Investigational Site Number 3800006
Milan, Italy
Site recruitment: Not reported
Investigational Site Number 3800005
Naples, Italy
Site recruitment: Not reported
Investigational Site Number 3800004
Roma, Italy
Site recruitment: Not reported
Investigational Site Number 3800003
Roma, Italy
Site recruitment: Not reported
Investigational Site Number 6420004
Bacau, Romania
Site recruitment: Not reported
Investigational Site Number 6420006
Brasov, Romania
Site recruitment: Not reported
Investigational Site Number 6420001
Bucharest, Romania
Site recruitment: Not reported
Investigational Site Number 6420008
Buzău, Romania
Site recruitment: Not reported
Investigational Site Number 6420003
Cluj-Napoca, Romania
Site recruitment: Not reported
Investigational Site Number 6420002
Oradea, Romania
Site recruitment: Not reported
Investigational Site Number 6420009
Targoviste, Romania
Site recruitment: Not reported
Investigational Site Number 6420007
Târgu Mureş, Romania
Site recruitment: Not reported
Investigational Site Number 6420005
Timișoara, Romania
Site recruitment: Not reported
Investigational Site Number 7030006
Bratislava, Slovakia
Site recruitment: Not reported
Investigational Site Number 7030002
Lučenec, Slovakia
Site recruitment: Not reported
Investigational Site Number 7030009
Ľubochňa, Slovakia
Site recruitment: Not reported
Investigational Site Number 7030005
Malacky, Slovakia
Site recruitment: Not reported
Investigational Site Number 7030007
Prešov, Slovakia
Site recruitment: Not reported
Investigational Site Number 7030001
Rožňava, Slovakia
Site recruitment: Not reported
Investigational Site Number 7030008
Sabinov, Slovakia
Site recruitment: Not reported
Investigational Site Number 7030004
Trenčín, Slovakia
Site recruitment: Not reported
Investigational Site Number 7030003
Žilina, Slovakia
Site recruitment: Not reported
Investigational Site Number 7240012
Alzira, Spain
Site recruitment: Not reported
Investigational Site Number 7240005
Barcelona, Spain
Site recruitment: Not reported
Investigational Site Number 7240002
Ferrol, Spain
Site recruitment: Not reported
Investigational Site Number 7240008
Málaga, Spain
Site recruitment: Not reported
Investigational Site Number 7240011
Pozuelo de Alarcón, Spain
Site recruitment: Not reported
Investigational Site Number 7240003
Quart de Poblet, Spain
Site recruitment: Not reported
Investigational Site Number 7240006
Sabadell, Spain
Site recruitment: Not reported
Investigational Site Number 7240007
Seville, Spain
Site recruitment: Not reported
Investigational Site Number 7240009
Seville, Spain
Site recruitment: Not reported
Investigational Site Number 7240004
Seville, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin

ClinicalTrials.gov · NCT04829903 · Registry updated: 2022-03-14

Condition / research focus: Type 2 Diabetes Treated With Insulin; Obesity; Adolescent Obesity
Sponsor: Corporacion Parc Tauli
Countries with listed sites: Pakistan
Registry dates and results: Start: 2020-01-02. Completion: 2021-11-20 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide (drug) — also listed as: Group DUL
Liraglutide (drug) — also listed as: Group LIR

Where the study takes place — 1 listed sites

Zainab Khan
Lahore, Punjab Province, Pakistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes

ClinicalTrials.gov · NCT04641312 · Registry updated: 2022-01-11

Condition / research focus: Healthy; Type 2 Diabetes
Sponsor: Eli Lilly and Company
Countries with listed sites: Germany
Registry dates and results: Start: 2020-11-25. Completion: 2021-12-21 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

LY3457263 (drug)
Dulaglutide (drug) — also listed as: LY2189265
Placebo (drug)

Where the study takes place — 2 listed sites

Profil Institut für Stoffwechselforschung
Neuss, North Rhine-Westphalia, Germany
Site recruitment: Not reported
Profil Mainz
Mainz, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3TerminatedINTERVENTIONAL

Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin

ClinicalTrials.gov · NCT03684642 · Registry updated: 2021-11-01

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: Sanofi
Countries with listed sites: Hungary · Poland · Ukraine · United States
Registry dates and results: Start: 2018-09-26. Completion: 2020-11-17 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Efpeglenatide (drug) — also listed as: SAR439977
Dulaglutide (drug) — also listed as: Trulicity™
Background therapy Metformin (drug)

Where the study takes place — 45 listed sites

Investigational Site Number 8400038
Birmingham, Alabama, United States
Site recruitment: Not reported
Investigational Site Number 8400035
Chandler, Arizona, United States
Site recruitment: Not reported
Investigational Site Number 8400005
Glendale, Arizona, United States
Site recruitment: Not reported
Investigational Site Number 8400054
Peoria, Arizona, United States
Site recruitment: Not reported
Investigational Site Number 8400057
Huntington Park, California, United States
Site recruitment: Not reported
Investigational Site Number 8400009
Los Angeles, California, United States
Site recruitment: Not reported
Investigational Site Number 8400007
San Diego, California, United States
Site recruitment: Not reported
Investigational Site Number 8400045
Spring Valley, California, United States
Site recruitment: Not reported
Investigational Site Number 8400040
Tustin, California, United States
Site recruitment: Not reported
Investigational Site Number 8400026
Van Nuys, California, United States
Site recruitment: Not reported
Investigational Site Number 8400050
Waterbury, Connecticut, United States
Site recruitment: Not reported
Investigational Site Number 8400055
Orlando, Florida, United States
Site recruitment: Not reported
Investigational Site Number 8400041
Pembroke Pines, Florida, United States
Site recruitment: Not reported
Investigational Site Number 8400025
Lawrenceville, Georgia, United States
Site recruitment: Not reported
Investigational Site Number 8400060
Meridian, Idaho, United States
Site recruitment: Not reported
Investigational Site Number 8400059
Skokie, Illinois, United States
Site recruitment: Not reported
Investigational Site Number 8400044
Lexington, Kentucky, United States
Site recruitment: Not reported
Investigational Site Number 8400061
Boston, Massachusetts, United States
Site recruitment: Not reported
Investigational Site Number 8400001
Bridgeton, New Jersey, United States
Site recruitment: Not reported
Investigational Site Number 8400039
New Windsor, New York, United States
Site recruitment: Not reported
Investigational Site Number 8400028
Burlington, North Carolina, United States
Site recruitment: Not reported
Investigational Site Number 8400036
Morehead City, North Carolina, United States
Site recruitment: Not reported
Investigational Site Number 8400013
Maumee, Ohio, United States
Site recruitment: Not reported
Investigational Site Number 8400014
Goose Creek, South Carolina, United States
Site recruitment: Not reported
Investigational Site Number 8400030
Dallas, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400020
San Antonio, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400043
San Antonio, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400053
San Antonio, Texas, United States
Site recruitment: Not reported
Investigational Site Number 8400037
Layton, Utah, United States
Site recruitment: Not reported
Investigational Site Number 8400049
Manassas, Virginia, United States
Site recruitment: Not reported
Investigational Site Number 3480004
Budapest, Hungary
Site recruitment: Not reported
Investigational Site Number 3480003
Debrecen, Hungary
Site recruitment: Not reported
Investigational Site Number 3480001
Gyula, Hungary
Site recruitment: Not reported
Investigational Site Number 3480005
Hatvan, Hungary
Site recruitment: Not reported
Investigational Site Number 3480002
Nyíregyháza, Hungary
Site recruitment: Not reported
Investigational Site Number 6160008
Gdansk, Poland
Site recruitment: Not reported
Investigational Site Number 6160004
Gdynia, Poland
Site recruitment: Not reported
Investigational Site Number 6160010
Katowice, Poland
Site recruitment: Not reported
Investigational Site Number 6160009
Poznan, Poland
Site recruitment: Not reported
Investigational Site Number 6160003
Warsaw, Poland
Site recruitment: Not reported
Investigational Site Number 6160001
Wroclaw, Poland
Site recruitment: Not reported
Investigational Site Number 8040003
Kyiv, Ukraine
Site recruitment: Not reported
Investigational Site Number 8040001
Kyiv, Ukraine
Site recruitment: Not reported
Investigational Site Number 8040002
Kyiv, Ukraine
Site recruitment: Not reported
Investigational Site Number 8040004
Vinnytsia, Ukraine
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM

ClinicalTrials.gov · NCT04466904 · Registry updated: 2021-07-23

Condition / research focus: Type 2 Diabetes
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Countries with listed sites: China
Registry dates and results: Start: 2020-09-12. Completion: 2021-05-28 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

IBI362 (drug)
Placebo (drug)
Dulaglutide (drug)

Where the study takes place — 1 listed sites

China Japan Friendship Hospital
Beijing, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes

ClinicalTrials.gov · NCT03668470 · Registry updated: 2021-07-08

Condition / research focus: Adult Subjects With Type1Diabetes and Insulin Microsecretion
Sponsor: Hospices Civils de Lyon
Countries with listed sites: France
Registry dates and results: Start: 2019-01-31. Completion: 2021-02-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide (drug)
Placebo (drug)

Where the study takes place — 7 listed sites

Service d'Endocrinologie, Maladies Métaboliques et Nutrition, CHU Grenoble, Hopital de la Tronche
La Tronche, France
Site recruitment: Not reported
Département d''Endocrinologie, Diabétologie, Nutrition ; CHU Montpellier ; Hôpital Lapeyronie, Avenue du Doyen Giraud
Montpellier, France
Site recruitment: Not reported
Service d'Endocrinologie, Maladies Métaboliques et Nutrition,CHU Nantes,Hôpital Nord Laennec,Bd Jacques-Monod,Saint-Herblain
Nantes, France
Site recruitment: Not reported
Service de Diabétologie et Maladies Métaboliques, Assistance Publique des Hôpitaux de Paris ;Hôpital Cochin, 27 rue du Faubourg Saint-Jacques
Paris, France
Site recruitment: Not reported
Service d'Endocrinologie, Diabétologie, Maladies de la Nutrition, Hospices Civils de Lyon, Centre hospitalier Lyon-Sud
Pierre-Bénite, France
Site recruitment: Not reported
Service de Diabétologie Maladies Métaboliques et Nutrition ; CHU Toulouse, Pôle cardiovasculaire et métabolique, Hôpital Rangueil ; 1, avenue du Professeur Jean Poulhès - TSA 50032
Toulouse, France
Site recruitment: Not reported
Service de Diabétologie, Maladies Métaboliques, Nutrition ; CHU Nancy ; Technopôle Nancy-Brabois ; Rue du Morvan,
Vandœuvre-lès-Nancy, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes

ClinicalTrials.gov · NCT03015220 · Registry updated: 2021-03-02

Condition / research focus: Diabetes; Diabetes Mellitus, Type 2
Sponsor: Novo Nordisk A/S
Countries with listed sites: Japan
Registry dates and results: Start: 2017-01-10. Completion: 2018-07-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Semaglutide (drug)
Dulaglutide (drug)

Where the study takes place — 34 listed sites

Novo Nordisk Investigational Site
Adachi-ku, Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Annaka-shi, Gunma, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Arakawa-ku, Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Chiba-shi, Chiba, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Fukushima, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Gunma, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Ibaraki, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Iruma-shi, Saitama, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Kanagawa, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Kashiwara-shi, Osaka, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Kawagoe-shi, Saitama, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Kawaguchi-shi, Saitama, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Kumamoto, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Kurashiki-shi, Okayama, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Kyoto-shi, Kyoto, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Mitaka-shi, Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Mito-shi, Ibaraki, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Miyazaki, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Osaka, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Ota-ku, Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Sapporo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Sapporo-shi, Hokkaido, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Sendai-shi, Miyagi, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Shimotsuke-shi, Tochigi, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Shinagawa-ku, Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Shizuoka-shi, Shizuoka, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Suita-shi, Osaka, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Toshima-ku, Tokyo, Japan
Site recruitment: Not reported
Novo Nordisk Investigational Site
Yamato-shi, Kanagawa, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)

ClinicalTrials.gov · NCT04143802 · Registry updated: 2021-01-20

Condition / research focus: Diabetes Mellitus, Type 2
Sponsor: Eli Lilly and Company
Countries with listed sites: United States
Registry dates and results: Start: 2019-12-18. Completion: 2020-12-28 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

LY3437943 (drug)
Dulaglutide (drug) — also listed as: LY2189265
Placebo (drug)

Where the study takes place — 4 listed sites

Anaheim Clinical Trials, LLC
Anaheim, California, United States
Site recruitment: Not reported
Miami Research Associates
Miami, Florida, United States
Site recruitment: Not reported
PRA International
Lenexa, Kansas, United States
Site recruitment: Not reported
Clinical Trials of Texas, Inc.
San Antonio, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?

ClinicalTrials.gov · NCT02846233 · Registry updated: 2020-11-10

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: University of California, San Francisco
Countries with listed sites: United States
Registry dates and results: Start: 2016-08. Completion: 2018-12 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GLP1 receptor agonist (drug) — also listed as: Albiglutide (Tanzeum) or , Dulaglutide (Trulicity)
basal insulin (drug) — also listed as: Lantus, Toujeo, NPH, levemir
SGLT2 inhibitor (drug) — also listed as: Empagliflozin (Jardiance)
Metformin (drug)

Where the study takes place — 1 listed sites

UCSF Fresno
Fresno, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus

ClinicalTrials.gov · NCT02597049 · Registry updated: 2020-06-17

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: Eli Lilly and Company
Countries with listed sites: Austria · Czechia · Germany · Hungary · Israel · Mexico · Puerto Rico · Spain · United States
Registry dates and results: Start: 2015-11. Completion: 2017-02 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide (drug) — also listed as: LY2189265
Placebo (drug)
SGLT2 inhibitor (drug) — also listed as: Canagliflozin, Dapagliflozin, Empagliflozin
Metformin (drug)

Where the study takes place — 41 listed sites

Medical Group of Encino
Encino, California, United States
Site recruitment: Not reported
National Research Institute
Huntington Park, California, United States
Site recruitment: Not reported
National Research Institute
Los Angeles, California, United States
Site recruitment: Not reported
New Horizon Research Center
Miami, Florida, United States
Site recruitment: Not reported
Metabolic Research Institute Inc.
West Palm Beach, Florida, United States
Site recruitment: Not reported
Cotton O'Neil Diabetes and Endocrinology Center
Topeka, Kansas, United States
Site recruitment: Not reported
JCMG Clinical Research
Jefferson City, Missouri, United States
Site recruitment: Not reported
Grand Street Medical PC
Brooklyn, New York, United States
Site recruitment: Not reported
Diabetes & Endocrinology Consultants PC
Morehead City, North Carolina, United States
Site recruitment: Not reported
PMG Research of Wilmington, LLC
Wilmington, North Carolina, United States
Site recruitment: Not reported
Dallas Diabetes Endocrine Center
Dallas, Texas, United States
Site recruitment: Not reported
Galenos Research
Dallas, Texas, United States
Site recruitment: Not reported
Endeavor Clinical Trials
San Antonio, Texas, United States
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Saint Stefan Ob Stainz, Austria
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Steyr, Austria
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Vienna, Austria
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Brandys Nad Labem-Stara Bolesl, Czechia
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Holešov, Czechia
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Krnov, Czechia
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Pardubice, Czechia
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Prague, Czechia
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Prague, Czechia
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Münster, Germany
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Oldenburg, Germany
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Budapest, Hungary
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Budapest, Hungary
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Debrecen, Hungary
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Nagykanizsa, Hungary
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Haifa, Israel
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Holon, Israel
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Jerusalem, Israel
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Monterrey, Mexico
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Monterrey, Mexico
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Zapopan, Mexico
Site recruitment: Not reported
Centro de Endocrinologia y Nutricion
Caguas, Puerto Rico
Site recruitment: Not reported
Manati Medical Center
Manati, Puerto Rico
Site recruitment: Not reported
Centro de Endocrinologia del Este
Yabucoa, Puerto Rico
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Alicante, Spain
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Málaga, Spain
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Seville, Spain
Site recruitment: Not reported
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Seville, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

ClinicalTrials.gov · NCT03495102 · Registry updated: 2020-06-12

Condition / research focus: Diabetes Mellitus, Type 2
Sponsor: Eli Lilly and Company
Countries with listed sites: Argentina · Austria · Canada · Greece · Hungary · Israel · Italy · Mexico · Poland · Puerto Rico · Romania · Russia · Slovakia · Spain · Taiwan · United States
Registry dates and results: Start: 2018-04-05. Completion: 2019-10-10 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide (drug) — also listed as: LY2189265

Where the study takes place — 208 listed sites

Synexus- Chandler
Chandler, Arizona, United States
Site recruitment: Not reported
Synexus/Central Arizona Medical Associates, PC
Mesa, Arizona, United States
Site recruitment: Not reported
Central Phoenix Med Clinic LLC
Phoenix, Arizona, United States
Site recruitment: Not reported
Arkansas Clinical Research
Little Rock, Arkansas, United States
Site recruitment: Not reported
Anaheim Clinical Trials, LLC
Anaheim, California, United States
Site recruitment: Not reported
Valley Research
Fresno, California, United States
Site recruitment: Not reported
National Research Institute
Huntington Park, California, United States
Site recruitment: Not reported
National Research Institute
Los Angeles, California, United States
Site recruitment: Not reported
Catalina Research Institute, LLC
Montclair, California, United States
Site recruitment: Not reported
Valley Clinical Trials, Inc.
Northridge, California, United States
Site recruitment: Not reported
Pacific Research Partners, LLC
Oakland, California, United States
Site recruitment: Not reported
National Research Institute
Panorama City, California, United States
Site recruitment: Not reported
Sierra Clinical Research
Roseville, California, United States
Site recruitment: Not reported
Artemis Institute for Clinical Research
San Diego, California, United States
Site recruitment: Not reported
Care Access Research
Santa Clarita, California, United States
Site recruitment: Not reported
Encompass Clinical Research
Spring Valley, California, United States
Site recruitment: Not reported
University Clinical Investigators, Inc.
Tustin, California, United States
Site recruitment: Not reported
Diablo Clinical Research
Walnut Creek, California, United States
Site recruitment: Not reported
Chase Medical Research, LLC
Waterbury, Connecticut, United States
Site recruitment: Not reported
ALL Medical Research, LLC
Cooper City, Florida, United States
Site recruitment: Not reported
Clinical Research of South Florida
Coral Gables, Florida, United States
Site recruitment: Not reported
Suncoast Research Group, LLC
Miami, Florida, United States
Site recruitment: Not reported
New Horizon Research Center
Miami, Florida, United States
Site recruitment: Not reported
Oviedo Medical Research
Oviedo, Florida, United States
Site recruitment: Not reported
Urban Family Practice Associates, PC
Marietta, Georgia, United States
Site recruitment: Not reported
In-Quest Medical Research, LLC- Peachtree Corners
Peachtree Corners, Georgia, United States
Site recruitment: Not reported
Pacific Diabetes & Endocrine Center
Honolulu, Hawaii, United States
Site recruitment: Not reported
East West Medical Institute
Honolulu, Hawaii, United States
Site recruitment: Not reported
Elite Clinical Trials LLLP
Blackfoot, Idaho, United States
Site recruitment: Not reported
Saltzer Medical Group. P.A.
Nampa, Idaho, United States
Site recruitment: Not reported
Prairie Education and Research Cooperative
Springfield, Illinois, United States
Site recruitment: Not reported
Synexus/Clinical Research Advantage
Evansville, Indiana, United States
Site recruitment: Not reported
Midwest Institute for Clinical Research
Indianapolis, Indiana, United States
Site recruitment: Not reported
Iderc, P.L.C.
West Des Moines, Iowa, United States
Site recruitment: Not reported
InterMed, PA
Portland, Maine, United States
Site recruitment: Not reported
MedStar Health Research Institute
Hyattsville, Maryland, United States
Site recruitment: Not reported
NECCR PrimaCare Research, LLC
Fall River, Massachusetts, United States
Site recruitment: Not reported
Aa Mrc Llc
Flint, Michigan, United States
Site recruitment: Not reported
Troy Internal Medicine, PC
Troy, Michigan, United States
Site recruitment: Not reported
Clinical Research Professionals
Chesterfield, Missouri, United States
Site recruitment: Not reported
StudyMetrix Research, LLC
City of Saint Peters, Missouri, United States
Site recruitment: Not reported
Montana Health Research
Billings, Montana, United States
Site recruitment: Not reported
Glacier View Research Institute
Kalispell, Montana, United States
Site recruitment: Not reported
Premier Research
Trenton, New Jersey, United States
Site recruitment: Not reported
Manhattan Medical Research
New York, New York, United States
Site recruitment: Not reported
Great Lakes Medical Research
Westfield, New York, United States
Site recruitment: Not reported
Metrolina Internal Medicine, P.A.
Charlotte, North Carolina, United States
Site recruitment: Not reported
Diabetes & Endocrinology Consultants PC
Morehead City, North Carolina, United States
Site recruitment: Not reported
Aventiv Research
Columbus, Ohio, United States
Site recruitment: Not reported
Intend Research
Norman, Oklahoma, United States
Site recruitment: Not reported
IPS Research Company
Oklahoma City, Oklahoma, United States
Site recruitment: Not reported
The Corvallis Clinic P.C.
Corvallis, Oregon, United States
Site recruitment: Not reported
Summit Research Network Inc
Portland, Oregon, United States
Site recruitment: Not reported
Heritage Valley Medical Group, Inc.
Beaver, Pennsylvania, United States
Site recruitment: Not reported
Detweiler Family Medicine
Lansdale, Pennsylvania, United States
Site recruitment: Not reported
Preferred Primary Care Physicians
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
Sudir Bansal M.D. Inc.
Warwick, Rhode Island, United States
Site recruitment: Not reported
PMG Research of Charleston, LLC
Moncks Corner, South Carolina, United States
Site recruitment: Not reported
Chattanooga Research and Medicine (CHARM)
Chattanooga, Tennessee, United States
Site recruitment: Not reported
Dallas Diabetes Endocrine Center
Dallas, Texas, United States
Site recruitment: Not reported
Southern Endocrinology and Associates PA
Mesquite, Texas, United States
Site recruitment: Not reported
Consano Clinical Research
Shavano Park, Texas, United States
Site recruitment: Not reported
Martin Diagnostic Clinic
Tomball, Texas, United States
Site recruitment: Not reported
ClinPoint Trials, LLC
Waxahachie, Texas, United States
Site recruitment: Not reported
Progressive Clinical Research
Bountiful, Utah, United States
Site recruitment: Not reported
Advanced Research Institute
Ogden, Utah, United States
Site recruitment: Not reported
Manassas Clinical Research Center
Manassas, Virginia, United States
Site recruitment: Not reported
Clinical Research Partners, LLC
Richmond, Virginia, United States
Site recruitment: Not reported
Capital Clincial Research Center
Olympia, Washington, United States
Site recruitment: Not reported
Walla Walla Clinic
Walla Walla, Washington, United States
Site recruitment: Not reported
Wenatchee Valley Hospital & Clinics
Wenatchee, Washington, United States
Site recruitment: Not reported
Prevea Clinic, Inc
Green Bay, Wisconsin, United States
Site recruitment: Not reported
Centro Medico CICEMO
Caba, Buenos Aires, Argentina
Site recruitment: Not reported
CEDIC-Centro de Investigaciones Clinicas
Caba, Buenos Aires, Argentina
Site recruitment: Not reported
Investigaciones Medicas IMOBA S.R.L.
Caba, Buenos Aires, Argentina
Site recruitment: Not reported
Centro de Investigaciones Metabólicas (CINME)
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
Site recruitment: Not reported
Centro Medico Dr Laura Maffei Investigacion Clinica Aplicada
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
Site recruitment: Not reported
Centro de Investigacion y Prevencion Cardiovascular (CIPREC)
Ciudad Autonoma de, Buenos Aires, Argentina
Site recruitment: Not reported
Instituto de Investigaciones Clinicas Mar del Plata
Mar del Plata, Buenos Aires, Argentina
Site recruitment: Not reported
CIPADI
Godoy Cruz, Mendoza Province, Argentina
Site recruitment: Not reported
AXISMED SRL - Bioclinica Research Network
Buenos Aires, Argentina
Site recruitment: Not reported
CENUDIAB
Ciudad Autonoma de Buenos Aire, Argentina
Site recruitment: Not reported
Centro Médico Viamonte
Ciudad Autonoma de Buenos Aire, Argentina
Site recruitment: Not reported
Instituto Centenario
Ciudad Autonoma de Buenos Aire, Argentina
Site recruitment: Not reported
Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff
Ciudad Autonoma de Buenos Aire, Argentina
Site recruitment: Not reported
Mautalen Salud e Investigación - Servicio de Endocrinología
Ciudad Autonoma de Buenos Air, Argentina
Site recruitment: Not reported
Instituto Medico Strusberg
Córdoba, Argentina
Site recruitment: Not reported
Centro Medico Privado San Vicente Diabetes
Córdoba, Argentina
Site recruitment: Not reported
Cent Priva Especiali Médicas Ambulatorias Inve Clin CEMAIC
Córdoba, Argentina
Site recruitment: Not reported
Landesklinikum Korneuburg-Stockerau, Standort Stockerau
Stockerau, Lower Austria, Austria
Site recruitment: Not reported
Universitätsklinikum Graz
Graz, Styria, Austria
Site recruitment: Not reported
Ordination Dr. Evelyn Fließer-Görzer
Saint Stefan Ob Stainz, Styria, Austria
Site recruitment: Not reported
VIVIT Institut am LKH Feldkirch
Feldkirch, Vorarlberg, Austria
Site recruitment: Not reported
KA Rudolfstiftung
Vienna, Austria
Site recruitment: Not reported
Zentrum für klinische Studien Dr. Ursula Hanusch GmbH
Vienna, Austria
Site recruitment: Not reported
Bailey Clinic
Red Deer, Alberta, Canada
Site recruitment: Not reported
Aggarwal and Associates Ltd
Brampton, Ontario, Canada
Site recruitment: Not reported
T. Nemtean Medicine Professional Corporation
Mississauga, Ontario, Canada
Site recruitment: Not reported
Bluewater Clinical Research Group Inc
Sarnia, Ontario, Canada
Site recruitment: Not reported
Stayner Medical Clinic
Stayner, Ontario, Canada
Site recruitment: Not reported
Dr. Anil K. Gupta Medicine Professional Corporation
Toronto, Ontario, Canada
Site recruitment: Not reported
Iatriko Palaiou Falirou, Medical Center
Palaió Fáliro, Athens, Greece
Site recruitment: Not reported
Laiko General Hospital of Athens
Ampelokipoi, Attica, Greece
Site recruitment: Not reported
Gen Hospital of Athens G Gennimatas
Athens, Attica, Greece
Site recruitment: Not reported
G.Papanikolaou General Hospital
Eksochi, Thessaloniki, Greece
Site recruitment: Not reported
Thermi Clinic
Thermi, Thessaloniki, Greece
Site recruitment: Not reported
Athens Euroclinic
Athens, Greece
Site recruitment: Not reported
University General Hospital of Larissa
Larissa, Greece
Site recruitment: Not reported
AHEPA Hospital
Thessaloniki, Greece
Site recruitment: Not reported
Ippokrateio General Hospital of Thessaloniki
Thessaloniki, Greece
Site recruitment: Not reported
Euromedica - General Clinic of Thessaloniki
Thessaloniki, Greece
Site recruitment: Not reported
Studium Egeszseghaz Kft.
Kalocsa, Bács-Kiskun county, Hungary
Site recruitment: Not reported
Kenezy Gyula Korhaz es Rendelointezet
Debrecen, Hajdú-Bihar, Hungary
Site recruitment: Not reported
Grof Esterhazy Korhaz es Rendelointezeti Szakrendelo
Pápa, Veszprém megye, Hungary
Site recruitment: Not reported
Szent Margit Rendelointezet
Budapest, Hungary
Site recruitment: Not reported
ClinDiab Kft.
Budapest, Hungary
Site recruitment: Not reported
Strazsahegy Medicina Bt.
Budapest, Hungary
Site recruitment: Not reported
TRANTOR 99 Bt.
Budapest, Hungary
Site recruitment: Not reported
Kanizsai Dorottya Korhaz
Nagykanizsa, Hungary
Site recruitment: Not reported
Zala Megyei Szent Rafael Korhaz
Zalaegerszeg, Hungary
Site recruitment: Not reported
Maccabi Diabetes Clinic, Grand Canyon, North District, Haifa
Haifa, Israel
Site recruitment: Not reported
Linn Medical Center
Haifa, Israel
Site recruitment: Not reported
Hadassah Medical Center
Jerusalem, Israel
Site recruitment: Not reported
Meir Medical Center
Kfar Saba, Israel
Site recruitment: Not reported
Clalit Health Services - Shuali Clinic
Raanana, Israel
Site recruitment: Not reported
ZIV Medical Center
Safed, Israel
Site recruitment: Not reported
Sakhnin Community Clinic, Clalit Health Services
Sakhnin, Israel
Site recruitment: Not reported
Diabetes Medical Center (DMC)
Tel Aviv, Israel
Site recruitment: Not reported
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Site recruitment: Not reported
Azienda Ospedaliera Universitaria Careggi
Florence, Florence, Italy
Site recruitment: Not reported
Istituto Clinico Humanitas
Rozzano, Milano, Italy
Site recruitment: Not reported
A.O.U. Senese Policlinico Santa Maria alle Scotte
Siena, SI, Italy
Site recruitment: Not reported
Azienda Ospedaliera Papa Giovanni XXIII
Bergamo, Italy
Site recruitment: Not reported
Policlinico Mater Domini
Catanzaro, Italy
Site recruitment: Not reported
Fondazione Universitaria degli Studi G D'Annunzio
Chieti, Italy
Site recruitment: Not reported
Ospedale Santa Maria Goretti
Latina, Italy
Site recruitment: Not reported
Policlinico Giaccone
Palermo, Italy
Site recruitment: Not reported
Ospedale Civile Maggiore Borgo Trento
Verona, Italy
Site recruitment: Not reported
Hospital Univ. Dr. Jose Eleuterio Gonzalez
Monterrey, Nuevo León, Mexico
Site recruitment: Not reported
Investigacion en Salud y Metabolismo S.C
Chihuahua City, Mexico
Site recruitment: Not reported
NZOZ ZDROWIE Osteo-Medic
Bialystok, Poland
Site recruitment: Not reported
Poradnia Diabetologiczna SN ZOZ Lege Artis
Bialystok, Poland
Site recruitment: Not reported
NS ZOZ Osrodek Diabetologiczny " Popula"
Bialystok, Poland
Site recruitment: Not reported
Centrum Badan Klinicznych, PI House
Gdansk, Poland
Site recruitment: Not reported
NZOZ Salvia s.c.
Katowice, Poland
Site recruitment: Not reported
NZOZ Diab-Endo-Met
Krakow, Poland
Site recruitment: Not reported
Centrum Terapii Wspolczesnej J.M. Jasnorzewska S.K.A.
Lodz, Poland
Site recruitment: Not reported
Gabinety Terpa
Lublin, Poland
Site recruitment: Not reported
NZOZ Przychodnia Specjalistyczna MEDICA
Lublin, Poland
Site recruitment: Not reported
Centrum Medyczne OMEDICA
Poznan, Poland
Site recruitment: Not reported
Praktyka Lekarska
Poznan, Poland
Site recruitment: Not reported
Nzoz Neuro - Kard
Poznan, Poland
Site recruitment: Not reported
NZOZ Przychodnia Specjalistyczna Henryk RudzkiAndrzej Wittek
Ruda Śląska, Poland
Site recruitment: Not reported
Centralny Szpital Kliniczny MSW
Warsaw, Poland
Site recruitment: Not reported
Regionalna Poradnia Diabetologiczna
Wroclaw, Poland
Site recruitment: Not reported
Research and Cardiovascular Corp.
Ponce, PR, Puerto Rico
Site recruitment: Not reported
Office: Dr. Luis Rivera Colon
San Juan, PR, Puerto Rico
Site recruitment: Not reported
Clinical Research Puerto Rico, Inc.
San Juan, Puerto Rico
Site recruitment: Not reported
GCM Medical Group PSC
San Juan, Puerto Rico
Site recruitment: Not reported
S. C. Grandmed S.R.L., Str.
Oradea, Bihor County, Romania
Site recruitment: Not reported
SC Gama Diamed SRL
Mangalia, Constanța County, Romania
Site recruitment: Not reported
Spitalul Judetean de Urgenta Satu Mare
Satu Mare, Jud Satu-Mare, Romania
Site recruitment: Not reported
CMI DNBM Dr. Pop Lavinia
Baia Mare, Maramureş, Romania
Site recruitment: Not reported
Cosamext SRL
Târgu Mureş, Mureș County, Romania
Site recruitment: Not reported
SC Diabmed Dr Popescu Alexandrina SRL
Ploieşti, Prahova, Romania
Site recruitment: Not reported
SC Dianutrilife Medica SRL
Ploieşti, Prahova, Romania
Site recruitment: Not reported
Centrul Medical Dr. Negrisanu
Timișoara, Timiș County, Romania
Site recruitment: Not reported
Centrul Medical de Diagnostic si Tratament Ambulatoriu Neomed SRL
Brasov, Romania
Site recruitment: Not reported
Cabinetul Medical Nicodiab SRL
Bucharest, Romania
Site recruitment: Not reported
Easydiet SRL
Bucharest, Romania
Site recruitment: Not reported
SC Nutrilife SRL
Bucharest, Romania
Site recruitment: Not reported
SC Medcon SRL
Buzău, Romania
Site recruitment: Not reported
Centrul Medical Unirea SRL
Cluj-Napoca, Romania
Site recruitment: Not reported
Cabinet Medical Urodiamed S.R.L.
Craiova, Romania
Site recruitment: Not reported
Milena Sante SRL
Galati, Romania
Site recruitment: Not reported
SC Olimpia Med SRL
Iași, Romania
Site recruitment: Not reported
Regional Clinical Hospital
Saratov, Russian Federation, Russia
Site recruitment: Not reported
Arkhangelsk Regional Clinical Hospital
Arkhangelsk, Russia
Site recruitment: Not reported
Arkhangelsk the first city clinical hospital
Arkhangelsk, Russia
Site recruitment: Not reported
Rostov State Medical University
Rostov-on-Don, Russia
Site recruitment: Not reported
City Hospital of Saint Martyr Elizabeth
Saint Petersburg, Russia
Site recruitment: Not reported
SPb GUZ "Diagnostic Center #85"
Saint Petersburg, Russia
Site recruitment: Not reported
Human care s.r.o.
Košice, Slovak Republic, Slovakia
Site recruitment: Not reported
MediVet s.r.o.
Malacky, Slovak Republic, Slovakia
Site recruitment: Not reported
Areteus s.r.o.
Trebišov, Slovak Republic, Slovakia
Site recruitment: Not reported
Diacrin s.r.o.
Bratislava, Slovakia
Site recruitment: Not reported
Noemis, s.r.o.
Nové Mesto nad Váhom, Slovakia
Site recruitment: Not reported
FUNKYSTUFF s.r.o.
Nové Zámky, Slovakia
Site recruitment: Not reported
MUDr. Jan Culak, s.r.o.
Prievidza, Slovakia
Site recruitment: Not reported
DIA-MED CENTRUM s.r.o.
Púchov, Slovakia
Site recruitment: Not reported
Tatratrial s.r.o.
Rožňava, Slovakia
Site recruitment: Not reported
Hospital Infanta Luisa
Seville, Andalusia, Spain
Site recruitment: Not reported
Clinica Juaneda
Palma de Mallorca, Balearic Islands, Spain
Site recruitment: Not reported
Corporació Sanitaria Parc Tauli
Sabadell, Barcelona, Spain
Site recruitment: Not reported
Hospital Universitario Marques De Valdecilla
Santander, Cantabria, Spain
Site recruitment: Not reported
Hospital Universitario Quiron Madrid
Pozuelo de Alarcón, Madrid, Spain
Site recruitment: Not reported
Instituto de Ciencias medicas
Alicante, Spain
Site recruitment: Not reported
Clinica San Pedro
Almería, Spain
Site recruitment: Not reported
Centre Medico Teknon
Barcelona, Spain
Site recruitment: Not reported
Hospital Clinico Universitario San Cecilio
Granada, Spain
Site recruitment: Not reported
Virgen de Las Nieves
Granada, Spain
Site recruitment: Not reported
Centro Especialidades San Jose Obrero (Barbarela)
Málaga, Spain
Site recruitment: Not reported
Clinica Nuevas Tecnologias en Diabetes y Endocrinologia
Seville, Spain
Site recruitment: Not reported
Hospital Universitario Virgen Macarena
Seville, Spain
Site recruitment: Not reported
Policlinica Galileo
Teruel, Spain
Site recruitment: Not reported
Chung Shan Medical University Hospital
Taichung, Taiwan
Site recruitment: Not reported
Taichung Veterans General Hospital
Taichung, Taiwan
Site recruitment: Not reported
Chi-Mei Medical Center
Tainan, Taiwan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

ClinicalTrials.gov · NCT03724981 · Registry updated: 2020-04-24

Condition / research focus: Diabetes Mellitus, Type 2
Sponsor: Eli Lilly and Company
Countries with listed sites: United States
Registry dates and results: Start: 2018-10-18. Completion: 2019-04-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide Pen (drug)
Semaglutide Pen (drug)

Where the study takes place — 14 listed sites

Valley Research
Fresno, California, United States
Site recruitment: Not reported
Long Beach Center for Clinical Research
Long Beach, California, United States
Site recruitment: Not reported
Palm Harbor Medical Associates
Palm Harbor, Florida, United States
Site recruitment: Not reported
Georgia Clinical Research
Snellville, Georgia, United States
Site recruitment: Not reported
Cedar-Crosse Research Center
Chicago, Illinois, United States
Site recruitment: Not reported
L-Marc Research Center
Louisville, Kentucky, United States
Site recruitment: Not reported
Evidera
Bethesda, Maryland, United States
Site recruitment: Not reported
Carolina Research Center, Inc.
Shelby, North Carolina, United States
Site recruitment: Not reported
Lillestol Research LLC
Fargo, North Dakota, United States
Site recruitment: Not reported
BRCR Medical Center, Inc.
Camp Hill, Pennsylvania, United States
Site recruitment: Not reported
Juno Research
Houston, Texas, United States
Site recruitment: Not reported
Juno Research, LLC
Houston, Texas, United States
Site recruitment: Not reported
PI-Coor Clinical Research, LLC
Annandale, Virginia, United States
Site recruitment: Not reported
Manassas Clinical Research Center
Manassas, Virginia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes

ClinicalTrials.gov · NCT03444142 · Registry updated: 2020-03-26

Condition / research focus: Diabetes Mellitus, Type 2
Sponsor: University of Guadalajara
Countries with listed sites: Mexico
Registry dates and results: Start: 2017-11-17. Completion: 2021-11-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Exenatide LAR (drug) — also listed as: Bydureon
Dulaglutide (drug) — also listed as: Trulicity

Where the study takes place — 1 listed sites

Instituto de terapeutica Experimental y Clinica. Centro universitario de Ciencias de la Salud. Universidad de Guadalajara
Guadalajara, Jalisco, Mexico
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists

ClinicalTrials.gov · NCT04184947 · Registry updated: 2020-03-11

Condition / research focus: Type 2 Diabetes
Sponsor: University of Padova
Countries with listed sites: Italy
Registry dates and results: Start: 2014-03-01. Completion: 2020-02-29 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

SGLT2 inhibitor (drug)
GLP-1 receptor agonist (drug)

Where the study takes place — 1 listed sites

Division of Metabolic Diseases, University Hospital of Padova
Padova, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

ClinicalTrials.gov · NCT03590626 · Registry updated: 2020-02-20

Condition / research focus: Non Alcoholic Fatty Liver Disease; Type2 Diabetes Mellitus
Sponsor: Medanta, The Medicity, India
Countries with listed sites: India
Registry dates and results: Start: 2019-01-01. Completion: 2020-02-18 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide (drug)

Where the study takes place — 1 listed sites

Division Of Endocrinology & Diabetes, Medanta The Medicity
Gurgaon, Haryana, India
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)

ClinicalTrials.gov · NCT02770885 · Registry updated: 2020-01-18

Condition / research focus: Primary Polydipsia
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2016-03. Completion: 2019-10-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dulaglutide (drug) — also listed as: Trulicity
Placebo (drug) — also listed as: Sodium Chloride 0.9%

Where the study takes place — 1 listed sites

University Hospital Basel
Basel, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →